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Summary 
Background: The number of people with cognitive impairment and dementia is increasing 
worldwide. This development will put considerable strain on health services, and it will be 
increasingly important to help people with dementia to live safely at home for as long as 
possible. One of the main threats to independent living is impairments in abilities related to 
mobility, such as balance, walking, and spatial navigation. These abilities are scarcely studied 
in clinical practice. Increased knowledge of the character of such mobility impairments in 
patients with mild cognitive impairment and dementia of various severity may help in the 
development of interventions aimed at postponing the loss of mobility skills.  
Aims:  The overall aims of this thesis were (1) to explore how mobility performance differs 
between groups with different levels of cognitive impairment (papers II and III) and how 
mobility changes over one year in people with early onset Alzheimer’s disease (AD) (paper 
I), and (2) to explore the relationship between mobility and different domains of cognitive 
function (papers II and III). 
Methods: This thesis includes three papers which all apply a cross-sectional design. We also 
applied a one-year longitudinal follow-up in paper I. The samples in the three studies mainly 
consist of patients recruited from memory clinics in Malmø, Sweden (paper I) and in Oslo, 
Norway (papers II and III). Paper I included 72 patients with early onset dementia in the 
cross-sectional part, and 25 of the 42 patients with early onset AD also attended a one-year 
follow-up. Paper II included 170 patients in three groups: 33 with subjective cognitive 
impairment (SCI) or mild cognitive impairment (MCI), 99 with mild AD, and 38 with 
moderate AD. In paper III, we used a subsample of 128 patients from the sample included in 
paper II: 19 with SCI, 20 with MCI, and 89 with mild AD.  
Outcomes:  In all three papers, we used performance-based measures of mobility. In paper I, 
we used timed measures of several mobility tasks. In paper II, we used the Balance 
Evaluation Systems Test (BESTest) to assess the various aspects of balance. In paper III, we 
used the Floor Maze Test to assess spatial navigation during walking. The cognitive domains 
were in papers II and III assessed using tests from the test battery in the Norwegian Dementia 
Register. 
ix 
 
Statistical analyses: Between-group differences were analyzed using different versions of 
analysis of variance (papers I and II), Chi-square tests (papers I and III) and the Mann-
Whitney U-test (paper III). The relationship between the mobility measures and the cognitive 
domains were analyzed using multiple regression analysis (papers II and III). Changes over 
time were analyzed using the paired samples t-test (paper I).  
Results:  Paper I: Patients with early onset AD had inferior mobility performance compared 
to patients with other forms of early onset dementia. The performance of the patients with 
early onset AD deteriorated from baseline to the one-year follow-up. Papers II and III: We 
found between-group differences (based on severity of cognitive impairment) in all aspects of 
balance measured by the BESTest and also in spatial navigation measured by the Floor Maze 
Test. The worst performance was in the group with the most pronounced cognitive 
impairment. Executive function was the only cognitive domain independently associated with 
all the mobility outcomes in the multivariate models.  
Conclusions: We found differences between each of the groups in all aspects of balance 
(paper II) and also in spatial navigation (paper III). In our longitudinal study of early onset 
AD we also saw a small decline in mobility over one year (paper I). Although our findings 
from these cross-sectional indicate a decline in mobility through the stages from SCI to MCI, 
mild AD, and moderate AD, these findings need to be confirmed in longitudinal studies. With 
regard to the second aim, executive function was associated with all aspects of balance, and 
also with spatial navigation. The explained variances were generally high in the models of the 
aspects of balance. However, for spatial navigation, the models provided only minor 
explained variances. Future studies are needed to validate the Floor Maze Test against real-
life navigation. 
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Definitions of central concepts 
The concepts are in general also defined the first time they appear in the thesis.  
 
Mobility is defined as the ability to move independently and safely from one place to another.
1
 
In this thesis we will use this term to also encompass balance and spatial navigation which are 
abilities that are essential to mobility.  
Cognition is the mental action or process of acquiring knowledge and understanding through 
thought, experience, and the senses.
2
 
Balance is used as a generic term describing the dynamics of body posture to prevent falling.
3
  
Walking is to move at a regular pace by lifting and setting down each foot in turn, never 
having both feet off the ground at once.
2
 In the thesis we will use walking and gait (i.e., the 
manner of walking) interchangeably. 
Spatial navigation is the ability to determine and maintain a route from one place to another.
4
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1 Introduction 
The increase in life-expectancy worldwide is a very positive development. However, 
conditions such as cognitive impairment and dementia become more common with age, and 
the number of people living with dementia is forecasted to increase dramatically in the years 
to come.
5
 Dementia is a leading cause of disability and institutionalization; it represents a 
substantial burden on family caretakers, and can be a financial burden on society in the 
western world. In 2010 the estimated costs of care associated with dementia in the United 
States were between 157 and 215 billion dollars.
6
 Although dementia is a key predictor for 
admission to nursing homes,
7
 most people with dementia live at home for many years before 
they are admitted to nursing home care.
8
 It is mandatory that we are able to provide secure 
and necessary care at home in order to maintain the quality of life of patients and their 
caretakers, but it is also important to meet the costs of care for society.  
Dementia is primarily characterized by decline of cognitive function that leads to severe 
impairments in activities of daily living. However, dementia also entails changes in emotional 
and affective behavior and deterioration of physical function such as mobility (i.e., the ability 
to move around). Among the dramatic events that frequently occur in relation to mobility in 
people with dementia are falls,
9;10
 and among the major risk factors for falls are gait and 
balance impairments, use of medication and cardiovascular instability.
10
 The consequences of 
falls for elderly persons with dementia are more severe than for persons without dementia, 
such as increased risk for hip fractures.
11
 Also, after a hip fracture they are less likely to 
recover function in terms of self-care and mobility,
12
 as well as a higher risk of admission to 
nursing home
13
 and of mortality.
14
 Still, knowledge on successful fall-preventive interventions 
for people with dementia have been scarce,
15
 however a recent review article concluded that 
physical exercise has a positive effect on preventing falls in older adults with cognitive 
impairment.
16
 Our study aims to provide a better understanding of balance abilities in relation 
to type and severity of cognitive impairments that may be useful for designing tailored 
interventions for persons with cognitive impairment and dementia. However, the relationship 
between physical exercise and cognition will not be addressed in this thesis.  
Getting lost is another dramatic event that occurs in relation to mobility in persons with 
dementia and causes concern and frequent intervention from caretakers. It is also a major risk 
for admission to nursing home.
17
 Walking outdoors is a valued and important part of 
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independent mobility, and there are many good reasons for encouraging such activity. 
Balancing the risk of getting lost with the benefit of physical activity and participation in 
activities is the dilemma many patients and their caretakers face on a daily basis. Systematic 
evaluation of patients’ navigational abilities in clinical practice is however almost absent, and 
in this thesis we will present a test that assesses spatial navigation during walking.  
My own interest in mobility in persons with dementia started when I worked as a physical 
therapist at a geriatric outpatient clinic at Bærum Hospital in Norway. When I started my 
clinical work, I knew very little about dementia, and even less about how dementia affected 
physical function. However, during the next years I examined hundreds of patients and held 
almost equally many discussions with my fellow physical therapist and the rest of the 
interdisciplinary team. Still I strived to assess, describe, and understand the movement 
patterns that I observed in the clinical assessments, such as the cautious gait and the lack of 
natural spontaneity in movements. The learning process and the curiosity I had for this field 
of mobility inspired me to engage in research on this topic. At the time I started my clinical as 
well as research career I discovered that there were relatively few research reports addressing 
mobility in patients with dementia. During my time as a Master’s student and as a Ph.D. 
student, the amount of research on mobility in persons with dementia has grown substantially, 
yet there are still many questions remaining on the interplay between cognition and mobility 
that requires interdisciplinary efforts.  
The main themes in this thesis, cognition and mobility, are complex constructs, as well as 
balance, navigation, executive function and the other constructs we have studied. While we 
have strived to shed light on this complexity in the thesis, we have been forced to make 
pragmatic choices to be able to study these complex themes, such as using single tests to 
represent each of the complex cognitive domains.  
The overall aim of the thesis is to explore the relationship between cognition and aspects of 
mobility in persons with cognitive impairment and Alzheimer’s disease. In particular, the 
focus will be on the relationships between mobility, particularly balance and spatial 
navigation and the following: a) severity of cognitive impairment/stages of cognitive decline, 
and b) different domains of cognitive function. A better understanding of the relationship 
between mobility and cognition may help clinicians and researchers to identify persons at risk 
of falling, getting lost, and functional decline, and to develop ideas for future interventions 
aimed at preventing these negative events persons with dementia.  
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2 Cognition, cognitive impairment and 
dementia 
Decline in cognitive function is the hallmark of dementia. Therefore, cognition as a construct 
will be presented as well as the conditions of cognitive impairment involved in this thesis.  
2.1 Cognition 
Cognition is derived from the Latin word “cognitio” which in turn comes from “cognocere” 
meaning “to come to know”.2 In modern literature the term cognition is often used to refer to 
our ability to think. More specifically, cognition may be defined as the mental action or 
process of acquiring knowledge and understanding through thought, experience, and the 
senses.
2;18
 Cognition is thus not a unitary concept and involves abilities such as perception, 
memory, reasoning, judgment and use of language. Given the diversity of abilities involved in 
cognition it is common to refer to cognitive domains in relation to assessment of cognitive 
function. Cognitive impairment refers to a decline in function in either one or several domains 
of cognitive function.
19
 To explore the relationship between mobility and cognition in depth, 
it is a necessary step to look beyond cognition as a uniform ability and also address the 
various cognitive domains. The classifications of the different cognitive domains vary 
between professional disciplines and traditions. In this thesis the focus will be on some of the 
most well-established cognitive domains that are relevant for mobility in persons with 
dementia: memory, executive function, attention, and spatial cognition.  
Memory is perhaps the most well-known cognitive domain that is declined in most dementia 
disorders. Memory is not a unitary concept, and several distinctions between subtypes are 
defined. Short-term memory refers to the ability to remember limited amounts of information 
for a very brief (i.e., seconds) period of time. Long-term memory on the other hand refers to 
the ability to remember both a larger amount of information and for longer periods of time.
20
 
Intact long-term memory function depends on the ability to both acquire, encode, store, and 
retrieve information.
21
 The long-term memory function involves both semantic memory of 
general facts and knowledge and episodic memory. Episodic memory is related to your own 
experiences (also called autobiographical memory) and also involves spatial and temporal 
characteristics of these experiences.
21;22
 Patients with Alzheimer’s disease (AD) often have 
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impairments of episodic memory, especially related to encoding and storing of new 
information.
23
 A typical clinical observation is when a patient forgets recent conversations, 
visits or events. A subdivision of long-term memory function is explicit and implicit memory; 
explicit memory requires conscious recollection of previous experiences,
21
 while implicit 
memory is a type of memory in which previous experiences aid the performance of a task 
without conscious awareness of these experiences, such as singing along a well-known song 
or brushing teeth.
24
 In this thesis the learning aspect of the memory function is emphasized 
given that this is a premise for establishing lasting memories.  
Executive function is another complex cognitive function, and can be defined as the ability 
to plan, initiate, monitor, and carry out goal-directed behavior.
25;26
 Executive function is 
considered as a higher-level cognitive function that implies a control function of other 
cognitive functions.
27
 To achieve effective goal-directed behavior it is not only important to 
be able to initiate and plan actions, but it is also important to be flexible, to be able to shift 
plans and to inhibit irrelevant information or responses during action. The prefrontal cortex is 
connected to more regions than any other region of the cortex, and it is described to have a 
central role in the integrity of executive functions.
25
 The inherent diversity of abilities 
involved in executive function is naturally difficult to grasp in single assessments, and they 
also entail a lack of a gold standard measure. In this thesis we have chosen to emphasize set-
shifting ability, which is a form of cognitive flexibility.  
Attention is another term commonly used in everyday language. In the research literature, 
attention is often divided into three main categories: selective, sustained, and divided 
attention.
28
 Selective attention is the ability to focus on certain objects, or stimuli, at the 
exclusion of others for brief periods of time. Sustained attention, also referred to as vigilance, 
is the maintenance of abilities to focus attention for a more extended time period. Divided 
attention refers to the ability to attend to two or more competing tasks simultaneously.
19;28
 
Attention is a cognitive ability often considered as a part of executive function. However, 
presently attention will be treated as a separate cognitive domain because there has been some 
focus on the relationship between attention and performance on mobility and balance tasks in 
healthy elderly.
29
 
Spatial cognition is the last cognitive domain to be emphasized in this thesis. It involves the 
interrelationships among people, objects, and space
30
 represented by visuospatial perception, 
mental imagery, spatial memory, and navigation.
31
 Two different aspects of spatial abilities 
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are emphasized: visuoconstruction and spatial navigation. Visuoconstruction is perhaps the 
aspect of spatial cognition that is most often assessed in cognitive/neuropsychological settings 
and involves the ability to draw or assemble visual stimuli in accordance with a specific 
design or mental image.
32
 
Spatial navigation is the main topic in paper III and may be defined as the ability to determine 
and maintain a route from one place to another.
4
 To maintain a sense of direction and location 
while moving around in the environment is a critical cognitive ability of both humans and 
animals. Successful navigation is traditionally associated with intact function of the medial 
temporal lobe (including the hippocampal formation), but it is also associated with other areas 
of the brain such as the parietal cortex, the prefrontal cortex, and the caudate nucleus.
33;34
 
Tasks related to spatial navigation is often divided into two reference frames for the 
navigator’s perspective: egocentric and exo (or allo-) centric navigation. In the egocentric 
reference frame the person uses him or herself as the center, while in the exocentric reference 
frame the person establishes his or her position based on an external (map-like) reference 
system.
35
 The exocentric reference frame has been linked to the hippocampal and 
parahippocampal regions,
36
 and it is therefore of particular interest to study in persons with 
AD. 
2.2 Conditions with cognitive impairment 
In this thesis, the focus is primarily on AD, although in paper I patients with other forms of 
dementia are also included. Since AD is a progressive, degenerative disease it is likely that 
the disease process begins in advance of the point in time where the patient’s symptoms are so 
pronounced that he or she fills the criteria for dementia. The idea or hypothesis of such a 
continuum is illustrated by Sperling and colleagues
37
 in Figure 1. During the last few decades 
there has been an increasing focus on the transitional phase between normal ageing and 
dementia. Persons that experience changes (i.e., decline) in their cognitive functioning 
without filling the criteria for dementia are of interest for clinicians and researchers that seek 
to identify persons at risk for developing AD and other dementias. The overall aim of 
studying persons with MCI is in most studies to be able to point out who will benefit from 
preventive efforts or potential future treatment for AD. In this thesis, however, we have 
included persons that have sought medical help for cognitive problems without filling the 
criteria for dementia in order to gain knowledge on the early changes of mobility related to 
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AD. Two at-risk-conditions are described in this continuum: subjective cognitive impairment 
(SCI) and mild cognitive impairment (MCI). These conditions will be presented later in this 
chapter. 
The challenge of doing research on the continuum leading to AD is that the intermediate 
stages between healthy ageing and dementia are naturally characterized by heterogeneous 
groups of persons with unequal future development ahead of them. To illustrate this, 
longitudinal studies of persons with MCI found that about 50% progressed to dementia (most 
to AD), 18% reverted to normal and the others remained stable.
38
 In the text we will refer to 
SCI and MCI as stages in the continuum leading to AD. However, we will underline that we 
are aware that both these conditions also cover people with other causes for their memory 
concern than incipient AD for instance depression or a physical disorder.  
 
Figure 1. A hypothetical model of the clinical trajectory of AD.
37
 Reprinted from 
Alzheimer’s & Dementia, 2011; 7(3), by Sperling and colleagues, with permission from 
Elsevier. The SCI condition is situated in the “preclinical” phase in this model. Note that this 
model do not imply that all persons in the preclinical and MCI phase will progress to 
dementia/AD. 
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2.2.1 Subjective cognitive impairment  
The earliest stage in the continuum from healthy ageing to dementia is often referred to as 
SCI. Several other terms are also used for this “almost-normal” condition, such as subjective 
memory complaints, subjective memory deficits, subjective cognitive decline, and as in 
Figure 1 preclinical dementia.
39;40
 Since SCI is not embedded in diagnostic frameworks, 
definitions may have varied between studies. Common characteristics in clinical studies (and 
also how we have identified patients with SCI in our study) include the following: subjective 
decline of memory or other cognitive function, performances within the normal range on 
cognitive/neuropsychological tests, and absence of dementia and mild cognitive impairment. 
In population studies, however, the presence of SCI have been established by simply asking 
“is your memory getting worse?”40 As a consequence the prevalence of subjective concern for 
memory in samples of community-based elderly varies widely.
41;42
 Many of those who report 
some sense of worsening of memory will never develop AD, however future cognitive decline 
is probably more likely if the concern for memory decline is so severe that the persons seeks 
medical help at a memory clinic.  
Longitudinal studies have found that persons with subjective memory complaints are more 
likely to develop further cognitive decline, MCI, or dementia than those who are not 
concerned about their memory function.
43-46
 Demographic characteristics may also help to 
identify persons with SCI that are most likely to progress to dementia. Van Oijen and 
colleagues
47
 found that the risk of AD was higher in persons with higher education than in 
persons with lower education in a sample of persons with SCI. One explanation for this may 
be that the cognitive screening tests have ceiling effects in persons with a high level of 
education, so that their changes in cognitive function go undetected. Another explanation 
could be that persons with a high level of education engage in activities that are cognitively 
more demanding than others, and this may make these persons more aware of even subtle 
changes in their cognitive function.   
Another way to study SCI as a stage of preclinical AD is to examine the relationship between 
SCI and brain changes related to AD. Such studies have found that subjective memory 
complaints are associated with atrophy of structures in the medial temporal lobe
48-50
 and AD 
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pathology at autopsy.
51
 These studies underline the potential of the SCI condition as a pre-
MCI stage in the development between healthy ageing and AD. 
It is important to remember that the pace of cognitive decline may be slow in this initial 
phase, which is also illustrated in Figure 1. Reisberg et al.
39
 suggested that the SCI stage of 
incipient AD may last up to 15 years before manifesting decline to MCI and dementia. A 
Swedish study that recruited participants from a memory clinic found that during the 3-year 
follow-up period, 88% of the patients that were diagnosed with SCI at baseline remained 
stable (i.e., did not develop MCI or dementia), while 60% of the patients with MCI remained 
stable.
52
 There are also studies that have not confirmed the association between SCI and 
future cognitive decline;
53
 however, in a follow-up study of the same population the authors 
concluded that memory complaints were an early manifestation of memory impairment.
54
 
Besides being associated with increased likelihood for future cognitive decline and dementia, 
subjective memory concerns are also associated with depression,
55-57
 personality traits,
57;58
 a 
number of different medical conditions, substance abuse, and medication. We are well aware 
of this heterogeneity, but we still believe that it is important to include this group of patients 
when exploring the relationship between cognition and mobility across the continuum of AD.  
2.2.2 Mild cognitive impairment  
The next stage on the continuum between healthy ageing and dementia is MCI. This condition 
has received massive interest in research since the first paper on MCI was published in 1988 
by Reisberg and colleagues.
59;60
 Several different criteria have been applied for MCI during 
the years; however there is considerable agreement that a person with MCI has some degree 
of cognitive impairments that can be confirmed by performances below reference values on 
various cognitive tests. At the same time a person with MCI has generally preserved abilities 
of daily living and thus does not fulfill the criteria for dementia.  
In 2004, the original Petersen/Mayo criteria
61
 which emphasized memory impairment were 
revised by an international working group to include impairments of other cognitive domains 
and to allow “minimal impairment” of complex daily functions.62 The new criteria, known as 
the Winblad criteria (which we have used in this thesis) are presented in Table 1. A recent 
study of patients attending Norwegian memory clinics reported impairments in complex 
activities of daily living in about 66% of the patients with a diagnosis of MCI.
63
 This finding 
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is in line with other studies.
64;65
 There is still no consensus for the degree of functional 
impairment that is acceptable within the MCI criteria, and the evaluation therefore requires 
the judgment of a clinician.  
 Table 1. The Winblad criteria for MCI
62
 
1. The persons is not normal, nor meet the criteria for dementia 
2. Evidence of cognitive deterioration for age: 
- Objective measured decline over time in cognitive task performance, and/or 
- Subjective report of decline by patient and/or informant and objective cognitive deficits 
3. Preserved activities of daily living and minimal to no impairment on complex instrumental 
functions 
Not all patients with MCI are typical representatives for the continuum between healthy 
ageing and dementia. MCI may also occur after stroke, and these patients may not have had 
any cognitive deterioration beforehand; they may also remain stable or improve their 
cognitive function in the recovery phase after the stroke.
66
 Clinical subtypes for MCI are also 
described according to the cognitive domain that is affected. The most common distinction is 
amnestic-MCI (characterized primarily by memory deficits) and non-amnestic-MCI (deficits 
in several cognitive domains, with or without memory deficits), and some also add a division 
for affection of a single domain or multiple domains.
62;67
 In this thesis we have not applied 
this sub-categorization of MCI, although the exclusion criteria we have applied in our studies 
probably makes the amnestic-MCI subtype most common. 
Prevalence studies have been conducted in several countries and in populations generally 
above 60 years old. The prevalence rates of MCI vary substantially across these studies, from 
3.2%
68
 to 24.3%,
69
 and this discrepancy probably reflects issues such as for example the use 
of different MCI criteria, use of cognitive tests, differences of age of the studied populations 
(the prevalence rates increase with age), and differences in design.
70
  
Several studies are conducted to assess how many converts from MCI to AD (i.e., conversion 
rates) and to identify predictors for conversion. A crucial factor for describing the conversion 
rate is the source of participants. Patients recruited from population-based samples have in 
general lower conversion rates than patients recruited from clinical settings such as memory 
clinics.
71
 Reviews of annual conversion rates for persons with MCI recruited from clinic 
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samples (similar to our sample) estimates approximately 10-15%, while for population-based 
samples this rate is generally less than 10%.
71
 A recent long-term population-based 
prospective study estimated that median dementia (AD) free survival time was 3.5 years from 
the onset of MCI, with a conversion rate of 7.3%.
72
 Established predictive factors for 
conversion include clinical severity, to be a apolipoprotein e4 carrier or not, and the presence 
of biomarker findings related to AD.
59
 Although many patients with MCI will remain 
cognitively stable or even revert to normal cognition, they still represent a high risk group for 
the development of AD and other dementias.
73
 The MCI condition is therefore of special 
importance in order to shed light on mobility across the stages of cognitive impairment in this 
thesis.  
2.3 Dementia 
Dementia is a syndrome caused by structural diseases of the brain. This implies that dementia 
is an umbrella term covering a variety of brain diseases. The characterizing main features are 
cognitive decline and changes in social and emotional behavior, and these characteristics are 
included in the International Statistical Classification of Diseases and Related Health 
Problems, version 10 (ICD-10) criteria for dementia which is presented in Table 2.
18
 The 
routines for evaluation and assessments of these characteristics are presented in the Methods 
section.  
Table 2. Diagnostic research criteria for dementia according to the ICD-10
18
 
I. Decline in: 
a) memory  
b) other cognitive abilities involving judgment and thinking, and in general processing of information 
II. Preserved awareness of the environment  
III. Decline in emotional control, motivation, or change in social behavior. 
State of cognitive decline must have lasted for more than 6 months.  
The degree of cognitive decline must be so severe that it affects the individuals’ ability to carry out 
activities of daily living.  
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Most brain disorders causing dementia are of a progressive nature. It is common to describe 
the progression of dementia in stages according to a combination of the severity of cognitive 
impairment and dependence in activities of daily living.
74;75
 Descriptions of three stages of 
dementia are incorporated in the ICD-10 diagnostic criteria for research in accordance to how 
the decline in memory and other cognitive abilities affects the ability to carry out activities of 
daily living.
18
 Severity of dementia is determined by the cognitive domain (e.g., memory or 
other cognitive functions) with most severe impairment, implying that a person with moderate 
decline in memory but only mild impairments of other cognitive abilities, has a moderate 
degree of dementia. 
Mild degree of dementia: The degree of memory loss or decline in other cognitive abilities is 
sufficient to interfere with everyday activities, but not so severe that it makes the person 
dependent on others. However, more complicated tasks cannot be undertaken.  
Moderate degree of dementia: The degree of memory loss or decline in other cognitive 
abilities makes the person incapable of living without support from others, and the person 
needs help in all tasks beside the most basic chores.  
Severe degree of dementia: The person no longer has the ability to retain new information, 
and often fails to recognize close relatives. 
2.3.1 Dementia disorders 
Dementia may be classified into three main types of disorders; the most common is 
degenerative brain diseases such as Alzheimer’s disease (AD), dementia with Lewy bodies, 
frontotemporal lobe dementia, and Parkinson’s disease with dementia. The second most 
common type is vascular dementia, which involves both small vessel disease and dementia 
after infarcts. The third category is secondary dementia which may originate from a variety of 
conditions such as alcoholism, brain tumors, encephalitis, head trauma, vitamin deficiency, 
endocrine disease, and several other conditions. Diagnostic precision is complicated by 
findings from autopsy studies that have shown that persons with dementia often have brain 
abnormalities related to more than one type of dementia (i.e., so called mixed dementias), 
which is more common in the oldest old patients with dementia.
76;77
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AD has a well established position as the most common disease leading to dementia; the 
prevalence of the other dementia disorders however varies from study to study.
77-79
 There are 
several reasons underlying the uncertain prevalence rates, such as which diagnostic criteria 
are applied and also which population are included in the studies. Overall, though, dementia 
with Lewy bodies and vascular dementia are considered as the second and third most common 
forms of dementia.
80;81
  
2.3.2 Alzheimer’s disease  
Alois Alzheimer diagnosed Auguste Deter with AD in 1906, which means it is now over 100 
years since the first patient was diagnosed with AD. Dr. Alzheimer described aggregated 
beta-amyloid in plaques and neurofibrillary tangles in Deter’s brain after her death, and these 
findings are still considered the neuropathologically hallmarks of AD.
82
 AD is a degenerative 
progressive disease that initially affects structures in the medial temporal lobe (such as 
entorhinal cortex and para-and hippocampal area) and then further affects other parts of the 
cortex (i.e., temporal, parietal and frontal lobes), while subcortical structures are largely 
spared.
83
 
Clinical presentation 
Clinically, persons with AD often experience memory impairments for recent personal events 
as one of their first symptoms. They may also have difficulties finding words, lose track of 
thoughts during conversation and get disoriented in familiar environments.
8;84
 Impairments in 
activities of daily living can initially be observed in more complex settings such as paying 
bills, learning to use new electronic equipment, and shopping, while later on there will be also 
be problems with more basic activities such as personal hygiene and getting dressed. Most 
persons with AD also experience behavioral changes such as increased irritability, apathy, 
anxiety, and depression.
85;86
   
According to the ICD-10, the clinical diagnosis of AD is made when the general clinical 
criteria of dementia are present, and there should be no evidence of any other type or causes 
of dementia. The diagnosis is further supported by signs of affection of cortical functions such 
as aphasia, apraxia, reduced motivation and drive, changes in social behavior, and evidence of 
cerebral atrophy, preferably shown to increase over time.
18
 Subtypes of AD are also defined, 
including AD with early onset, AD with late onset and atypical or mixed AD. The most 
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common subtype is the late onset AD that is characterized by onset after 65 years and 
evidence of slow, gradual onset and progression with primarily affection of memory. Given 
that approximately 95% of all cases have late onset AD, the general description of AD in this 
thesis is primarily related to this subtype. However, since paper I concerns mobility in 
patients with early onset AD, this subtype will be presented more explicitly later in this 
section. 
Epidemiology 
AD is the most prevalent dementia disorder and accounts for about 60% to 70% of all cases of 
dementia.
87
 The importance of ageing on development of AD has substantial influence on the 
estimated future prevalence of AD. About one in nine persons aged 65 years and above has 
AD;
8
 however, among persons above 85 years old the number increase to one in three.
88
 A 
recent systematic review and meta-analysis estimated that about 35.6 million people 
worldwide had dementia in 2010, and the majority of these will probably have AD.
5
 Further, 
the authors of that study expected the numbers to double every 20 years to 65.7 million in 
2030 and 115.4 million in 2050. This increase is mostly attributed to the expected increase of 
people with dementia in low and middle income countries. There are, however, also 
indications that generational cohort effect exists in prevalence of dementia, suggesting that 
later-born generations have a lower risk of dementia than previous generations in the past 
century.
89
 This study was carried out in England, and it is uncertain to what extent these 
findings apply for low and middle income countries. There are no certain numbers on how 
many have AD in Norway, but approximations based on the Rotterdam-study in conjunction 
with a small Norwegian study forms estimates that around 70 000 persons may have dementia 
in Norway today.
90;91
   
Risk factors 
The underlying cause leading to AD is still not established; however, several risk factors for 
the development of AD have been identified, including both genetic and non-genetic risk 
factors and also protective factors. Gene mutations in one of three genes—amyloid precursor 
protein, presenilin 1 and presenilin 2—are the cause of AD in less than 5% of patients with 
AD, and these rare forms of familiar AD usually exhibit an early onset.
92
 Among several 
potential risk genes, the ApoE e4 allele entails 3-10 times increased risk of AD.
93;94
 The non-
genetic risk factors includes both non-modifiable factors such as ageing, which is the overall 
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most important risk factor, and modifiable factors such as presence of cerebrovascular 
disease, depression, elevated blood pressure, diabetes, metabolic syndrome, smoking, alcohol, 
and a history of traumatic brain injury.
92;94;95
 The best established protective factors include 
physical activity, exercise, intellectual activity and education.
94;96
 Social participation is also 
recognized as a protective factor from development of AD.
97
  
Early onset Alzheimer’s disease 
The ICD-10 diagnostic criteria for the early onset subtype of AD includes onset before 65 
years, a relatively rapid onset and progression (compared to late onset AD), and in addition to 
memory impairment there should also be signs of temporal, parietal, and/or frontal lobe 
involvement such as aphasia, agraphia, and apraxia.
18
 The age cut-off is an arbitrary division 
based on sociological aspects such as retirement age rather than biological age, and it is 
generally accepted that the early onset and late onset subtypes do overlap.
98
 Early onset AD is 
a rare condition compared to the late onset subtype. Recent prevalence estimates suggest that 
there are 10.6 to 153 persons with early onset AD per 100 000 of the population.
99
 AD is the 
most common form of early onset dementia; however, AD is relatively less common than in 
late onset dementia.
100;101
 Frontotemporal lobe dementia is relatively more common in early 
onset than in late onset dementia.
102-104
  
Several studies have examined clinical differences between early and late onset AD. Non-
memory and atypical presentations such as apraxia and impairments in executive and 
visuospatial function are more common in patients with early onset AD than in patients with 
late onset AD.
105-108
 This atypical clinical presentation combined with the notion of AD as a 
disease of old age may explain why the time to get the correct diagnosis is generally longer 
for persons with early onset AD compared to late onset AD.
109
 Although the ICD-10 list 
“relatively rapid progression” as a criterion for the early onset subtype of AD, inconsistent 
findings regarding whether early onset AD is characterized by rapid progression exists.
110-112
 
Compared to persons without dementia at the same age, persons with early onset have 
elevated risk for mortality.
113;114
  
There is no doubt that AD is a devastating condition for all affected regardless of age. 
However, persons that develop dementia in their 50s and 60s are part of the work force, and 
often they have responsibilities for children still living at home. The early onset subtype, 
therefore, raises some particular challenges beyond the diagnostic process. Caretakers (often 
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spouses and children) have reported frustration, grief, and loneliness because of dementia in 
the family, and conflicts between children and the affected parent was common. Reduced 
income and financial problems are also common findings both related to the patient not being 
able to work longer, but also because many caretakers had reduced their working hours to 
care for their family member with dementia.
115;116
 
Most research is naturally focused on late onset AD since this is the most common form of 
AD, and there is still few studies involving the early onset subtype of AD. It is therefore a 
need to gain more knowledge on the condition itself and to study mobility in dementia in 
patients less disturbed by the normal changes related to ageing.   
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3 Mobility 
In this thesis mobility is defined as the ability to move independently and safely from one 
place to another.
1
 So mobility is an essential part of activities of daily living, of participation 
in cultural, social, and physical activities and thus of importance for quality of life. Mobility is 
known to decline with higher age even in healthy elderly,
117;118
 and impairments of mobility 
are closely related to functional decline and disability.
119
 
The understanding of mobility in this thesis is based on the systems approach for motor 
control as described by Shumway-Cook and Woollacott.
1
 This approach looks upon motor 
control and movement as the result of interaction between the individual, the task, and the 
environment. A person’s functional capacity for movement is thus determined by the person’s 
capacity to undertake the demands by the task and the environment.
120
 While this theory most 
often refers to “motor control”, the same conceptual model may just as well refer to 
“mobility”, and this is how the model will be referred to further in this thesis. Complex 
cooperation between several interrelated systems within the individual is necessary for 
successful mobility. Broadly, these systems concern perception (i.e., integration of sensory 
impressions to meaningful information), cognition (i.e., the central processing and modulation 
to achieve specific goals or intents) and action (i.e., the motor output from the central nervous 
system).
1
  
During the last few decades, the systems approach has also been applied to explain and 
understand balance.
121-123
 There is no universal definition of balance, and different terms such 
as postural control, balance, postural stability, are often used interchangeably.
124
 In this thesis, 
we consider these terms as synonyms, and the term balance will be used throughout the text. 
Balance may in a wide-sense be defined as “a generic term describing the dynamics of body 
posture to prevent falling,”3 or more specifically as the ability to regulate the body’s position 
in space for the dual purposes of stability and orientation.
1
 Regardless of definition balance is 
a prerequisite for our ability to carry out everyday activities in a safe and efficient manner. 
The human body has a relatively narrow base of support, a high center of gravity and many 
moveable joints, so the act of maintaining balance while in an upright stance is a demanding 
task.
124
 The complex interaction to achieve balance includes both musculoskeletal and neural 
systems.
1;121
 The musculoskeletal systems involve factors such as biomechanical alignment, 
joint range of motion, muscle strength, etc. The neural systems include both peripheral and 
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central processes, such as motor processes (i.e., organization of neuromuscular synergies for 
coordinated functional movements), sensory processes (i.e., organization and coordinating 
information from visual, vestibular, and somatosensory systems) and higher level processes 
(i.e., cognitive influences that also provide adaptive, and anticipatory adjustments).
1
  
The functional goals of these systems are to maintain postural alignment (e.g., while sitting or 
standing) to facilitate voluntary movement such as reaching forward, and to recover from 
external disturbances such as a slip on icy pavement.
122;124
 The strategies to achieve these 
goals can be either proactive/anticipatory, reactive/compensatory, or a combination of 
these.
125;126
 The natural consequence of not being able to maintain balance is falling, so 
“balance” is as an important topic for both physical therapists and other health professionals. 
The systems approach for balance has implications for how physical therapists should address 
balance impairments by seeking to determine which underlying aspects of balance are 
impaired in order to tailor interventions.
121;122;127
 
Balance is challenged in various degrees during the different mobility tasks, and one of the 
most demanding tasks is walking. Human walking is typically characterized by a symmetrical 
alternating gait pattern.
128
 During the step cycle, the line of gravity will fall outside the base 
of support, and we keep repeating this unstable maneuver over and over again.
3
 Walking is 
therefore a demanding mobility task that can be described by three requirements the systems 
theory relate to all mobility tasks; progression, stability and adaptation. Progression is 
generated during walking by coordinated rhythmic patterns of muscle activation of the legs 
and the upper body to move the person’s body in the desired direction. Stability is constantly 
challenged during walking, and walking has therefore been compared to a series of controlled 
falls. When the surface changes or we are disturbed, we need to be able to adapt to these 
changes.
1
 This understanding underlines the importance for intact balance control for efficient 
and safe walking, which is also expressed in the frequently used “gait and balance” term.  
Walking was for a long time considered as an automatic motor task that did not require 
cognitive influence. However, during the last few decades a lot of research has focused on the 
cognitive contributions, in line with the systems approach, to walking performance. Lundin-
Olsson and colleagues 
129
 demonstrated in 1997 that elderly who “stopped walking while 
talking” were more prone to falling than those who were able to sustain conversation during 
walking. Since then, this dual task approach has been the most common method for testing 
whether walking requires attention.
29;130
 The underlying rational is that if walking is 
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independent of attentional resources, then there would be no affection of walking when the 
persons simultaneously performs other tasks such as manual tasks (e.g., carrying a tray) or 
cognitive tasks (e.g., counting backwards).
131
 However, even healthy young people display 
decreased cognitive performance while walking as long as the cognitive task is sufficiently 
difficult.
131;132
 Walking is therefore no longer considered as solely an automated motor 
activity independent of cognitive influence. In the three papers in this thesis, walking has been 
used in different ways to explore mobility in persons with cognitive impairment. In paper I, 
walking is represented by tasks such as walking on a flat surface and also stair walking. In 
paper II, balance is examined during dynamic walking tasks in the last subscale of the 
BESTest. In paper III, we have examined performances in spatial navigation where the 
patients must figure out the correct pathway to walk.  
Few studies (other than the dual task studies) have focused on the relationship between 
mobility and impairments in separate cognitive domains in persons with AD. The studies that 
have looked into this relationship have found associations between executive functioning and 
various measures of gait stability,
133-135
 but not with gait speed.
134
 Limitations of these studies 
involve small samples and limited exploration of other cognitive domains. A study of gait in 
patients with MCI did however include global cognition, working memory, executive 
function, and attention as independent variables, and working memory was the only factor 
that remained significantly associated with slow gait after adjustments.
136
  
The systems theory is a useful approach to gain understanding of motor control, movement, 
balance, and walking. However, in order to make meaningful use of walking skill in the 
community, it is also necessary to be able to navigate in both familiar and unfamiliar 
surroundings. Although the systems theory emphasizes that movement emerges from 
interactions between the individual, the task, and the environment, the individuals’ ability to 
maneuver in the environment is not properly addressed in this approach. Patla and Shumway-
Cook
137
 provided a thorough description of eight environmental factors related to independent 
mobility in the community, however, the ability to navigate in the community did not receive 
much attention. Spatial navigation is not defined as part of the cognitive process described in 
the systems theory; however, it is in this thesis incorporated in the extended understanding of 
mobility as a construct.   
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4 Mobility in persons with SCI, MCI 
and AD 
In the review of the literature regarding mobility in persons with cognitive impairment and/or 
AD, studies that were published up to 2010 are included, as these formed the literature base 
on which we designed our study. More recent studies will be included in the discussion 
section of the thesis.  
For a long time persons with mild degrees of AD were thought to show no kind of mobility 
limitations.
138
 This understanding was also incorporated in formal documents such as the 
National Institute of Neurological and Cognitive Disorders and Stroke-Alzheimer’s Disease 
and Related Disorders Association criteria for AD published in 1984, where disturbances of 
gait in an early stage of AD would argue against a diagnosis of probable AD.
139
 Later, several 
studies confirmed that mobility impairments are more common in other dementias than 
AD,
140-143
 but studies also demonstrated conflicting results such as no difference in gait speed 
between persons with AD and dementia with Lewy bodies dementia.
144
 The lack of focusing 
on mobility in the early 80s is also seen in the Global Deterioration Scale for Assessment of 
Primary Degenerative Dementia, published in 1982, which does not describe decline of 
walking until severe stages of dementia.
145
 The Clinical Dementia Rating scale, also 
published in 1982, incorporates six domains of cognition and functioning but does not 
mention physical function at all.
146
 
The first paper I have found with focus on gait and balance impairments in patients with AD 
dates back to 1983 when Henriet Visser compared 11 patients with AD of moderate degree 
with healthy age- and sex-matched control persons. She reported that the patients with AD 
had shorter step lengths, lower gait speed, lower stepping frequency, greater step variability, 
and greater sway path than the control persons without dementia.
147
 During the last two 
decades the interest for physical function and mobility in persons with cognitive impairment 
and AD has evolved tremendously.  
Several approaches are used to understand the development of mobility impairments related 
to severity of cognitive decline in persons with AD. The gold standard would be longitudinal 
studies following a large cohort of healthy persons for a long period of time. In that way one 
would be able to describe the first subtle changes as well as the development throughout the 
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course of preclinical dementia and further through the stages of AD. However, given a series 
of practical reasons, as far as I know no such studies exist. The knowledge of development of 
decline in mobility is therefore gathered from longitudinal studies of shorter time spans as 
well as cross-sectional studies that have compared groups of persons at different degree of 
cognitive impairment and stages of dementia.  
4.1 Mobility impairments in persons with SCI and 
MCI 
To the author’s knowledge, no study of mobility in persons with SCI exists. Probably this is 
related to the heterogeneous character of the condition. Several studies of mobility in persons 
with MCI have been published, and most studies have focused on comparisons of walking 
abilities between persons with MCI and healthy controls. In general the findings of these 
studies indicate that persons with MCI have worse performances on different aspects of 
walking (e.g., clinical evaluation of gait, gait speed, stride length and variability, and dual task 
walking) compared to healthy controls.
148-154
 Differences in gait performance are found in 
both amnestic and non-amnestic groups of MCI compared to a healthy control group.
151
 
Fewer studies have examined balance in populations with MCI, although studies have found 
differences in postural sway between persons with MCI and healthy controls using platform 
systems.
155;156
 Mobility impairments have also been associated with disability in persons with 
MCI.
149
 However studies have been published that have not been able to detect differences 
between persons with MCI and healthy controls, these studies used clinical balance and 
walking tasks as outcome variables.
157;158
 Although several studies have been conducted in 
this field, this thesis will provide a more comprehensive assessment of the various aspects of 
balance in persons with MCI than has been previously published.  
4.2 Mobility impairments in persons with AD 
In this section I will first present estimates of prevalence of mobility impairments in AD, and 
then I will look at studies that have examined the relationship between severity of cognitive 
decline and mobility either in cross-sectional studies or in longitudinal studies. Lastly, studies 
of the relationship between mobility and cognitive domains, in particular spatial navigation, 
will be reported.  
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The prevalence of gait disorders or mobility impairments is hard to establish given various 
outcome measures and the large heterogeneity in the characteristics of the involved sample of 
participants. Most studies report prevalence rates of gait and/or balance impairments between 
30% and 50% in home-dwelling persons with AD.
159-162
 The corresponding rates in healthy 
control persons in these studies are between 7% and 26%.
141;159-162
 The lowest prevalence rate 
of gait impairments was reported in Allan’s141 study, where 25% of the patients with AD had 
gait impairments (measured by the Tinnetti scale). The highest rate was reported by Thomas 
and colleagues,
142
 who found gait impairments in 52.7% using a clinical evaluation of 
concern for the safety of independent walking as an outcome measure. Regardless of 
methodological issues, all these studies reported more gait and/or balance impairments in 
persons with AD than in healthy controls.
141;159-162
 Thus, there is a need for more knowledge 
on the development and the character of mobility impairments in persons with AD at different 
stages.  
Comparisons of mobility impairments across the continuum of AD  
Studies have shown that persons with AD display worse performances on several different 
aspects of walking compared to cognitively healthy controls such as slower gait, increased 
gait variability or other deviations of gait pattern,
134;144;147;154;157;158;163-167
 more pronounced 
effects of dual task on gait,
153;168
 and also lower scores on composite scores of walking tasks 
or lower-extremity function.
141;148
 Balance impairments are also more pronounced in patients 
with AD than in healthy control groups, as studies using clinical outcomes such as Bergs 
balance scale
166
 and the Tinnetti balance scale
141
 have shown. Various platform systems have 
also been used to detect more subtle changes in postural sway, and they have identified 
differences between persons with AD and healthy controls.
147;155;165;169
 Deterioration of 
balance with increasing severity of AD was found in a study where impairments on the 
Tinnetti balance scale was related to lower Mini Mental Status Examination (MMSE) scores 
and low ADL scores.
170
 
A handful of studies have compared mobility performances between groups of healthy 
controls and groups with MCI and AD. Such studies are of special importance for the 
understanding of mobility related to the continuum between healthy ageing and AD (Table 3).
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Table 3. Overview of selected studies comparing mobility performances between groups of healthy controls, MCI and AD.  
Author, year Groups, n Age, mean (SD) or median (range) Main outcomes Main findings 
Pettersson,  
2005
157
 
Healthy: 33 
MCI:  51 
AD: 22 
57 (9.2) 
60 (7.3) 
68 (9.9) 
Bergs Balance scale 
Tinetti Gait 
Timed Up and Go 
Healthy vs MCI: no differences 
MCI vs AD: no differences 
Eggermont, 
2010
150
 
Healthy: 22 
MCI:  22 
AD: 22 
76.5 (7.4) 
76.3 (8.1) 
77.1 (9.6) 
Gait speed 
Timed Up and Go 
Sit to stand 
Healthy vs MCI: Gait speed slower in MCI group, other no 
differences 
MCI vs AD: no differences 
Goldman,  
1999
158
 
Healthy: 43 
MCI:  40 
AD: 20 
73.2 (7.7) 
72.0 (7.5) 
73.7 (7.8) 
Gait speed Healthy vs MCI: no difference 
MCI vs AD: AD slower than MCI 
Pettersson,  
2007
171
 
Healthy: 25 
MCI:  6 
AD: 6 
55 (4.7) 
59 (3.4) 
58 (1.9) 
Gait speed 
Gait speed dual task 
Healthy vs MCI: no differences 
AD slower than healthy group 
MCI vs AD: not reported 
Nakamura,  
1997
165
 
Healthy: 15 
Mild AD: 15 
Moderate AD: 15 
Severe AD : 15 
77.1 (3.4) 
75.9 (3.6) 
77.5 (4.0) 
78.1 (3.2) 
Postural sway 
Gait speed 
Healthy vs mild AD: no differences in gait 
Postural sway increased with each stage of AD 
 
Leandri, 
2009
155
 
Healthy: 15 
MCI:  15 
AD: 15 
76.0, 70-86 
77.6, 69-84 
77.6, 66-84 
Postural sway Healthy vs MCI: sway increased in MCI 
MCI vs AD: sway increased in AD 
 
Aggarwal, 
2006
148
 
Healthy: 558 
MCI:  198 
AD: 60 
74.6 (6.7) 
78.7 (7.0) 
81.9 (3.1) 
Lower limb function 
(gait, balance, sit to 
stand) 
Healthy vs MCI: MCI more impaired 
MCI vs AD: AD more impaired 
SD = standard deviation. 
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The findings from the cross-sectional studies presented in Table 3 are not entirely consistent 
to the MCI condition’s role as an in-between-group of healthy ageing and AD with regard to 
mobility level. The study with the largest sample size (n=816) conducted by Aggarwal and 
colleagues
148
 found that mobility performances of persons with MCI were inferior to 
cognitively healthy persons but were still superior to persons with AD. However, their sample 
was part of the Religious Order Study and involved only Catholic clergy members; this raises 
questions about the generalizability of their study to other populations. A general drawback of 
most of the other studies is the relatively low sample sizes. Pettersson’s study from 2007171 is 
the only study using well-established outcomes in a population of early onset AD of which I 
am aware. Unfortunately the group of early onset AD consisted of only six patients, which 
limits the generalizability of the findings. Mobility in patients with early onset AD is 
therefore a largely unexplored area of research. Compared to walking there are relatively few 
studies of balance, and also very few studies that involve comparisons of different stages of 
AD. It also seems clear that evaluation of mobility performances in the early phases of 
cognitive impairment and dementia demands sensitive assessment tools without ceiling 
effects.   
Mobility performances observed in longitudinal studies 
The few longitudinal studies of mobility in persons with AD confirm the impression from the 
findings in the cross-sectional studies, that a decline in cognition is associated with a decline 
in mobility. Hebert and colleagues followed-up with a group of home-dwelling persons with 
AD for up to 4 years.
172
 They concluded that physical performance declined over time, and 
that a faster decline was seen in those with lower cognitive score at baseline. It should be 
noted that the mean score of the MMSE at baseline was as low as 13.5 points (SD 8.1); this 
indicates a moderate to severe degree of dementia. Scarmeas and colleagues studied 
parkinsonian signs (e.g., rigidity, bradykinesia, posture/gait abnormalities) in persons at early 
stages of AD for a mean period of 3.6 years, and they found that the prevalence of the 
posture/gait sign increased as the disease progressed.
173
 Another study of parkinsonian signs 
in persons with AD reported an 8.9% increase of the gait and posture score over a 4-year 
follow-up.
174
 Change over time was also investigated in a study of quantitative measures of 
walking with a one-year follow-up of patients with mild and moderate degrees of AD.
175
 The 
results showed reduced gait speed and stride length and an increase in double support and 
stride variability.  
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Most longitudinal studies have not focused on the development of mobility impairments. 
Instead they have used mobility measures as predictors for future cognitive decline and thus 
do not necessary provide information that is fruitful for designing interventions. The presence 
of gait and posture impairment as well as quantitative gait measures such as gait speed, 
variability, and stride length have consistently been identified as independent predictors of 
future cognitive decline
176-180
 and dementia
159;180-182
 in longitudinal studies of community-
dwelling cognitively healthy persons. Other studies have found that the degree of gait and 
balance dysfunction was related to risk of AD in persons with MCI
148
 and that disturbed gait 
or balance performances predicted higher rates of cognitive decline
159;183-185
 and increased 
risk for institutionalization and mortality
186
 in persons with AD. These studies indicate that 
mobility impairments may occur at a very early phase of dementia and that interventions 
aimed at preventing this decline therefore should start as early as possible.  
4.3 Mobility and spatial navigation in persons with 
SCI, MCI, and AD 
In this thesis, the cognitive ability of spatial navigation is emphasized as an essential skill for 
independent mobility in society. Failure in spatial navigation may lead to topographical 
disorientation, i.e., the inability to find one’s way in large-scale environments.187 Large-scale 
environments refer to buildings, neighborhoods, cities etc., and require walking or other forms 
for locomotion.
188
 The ultimate consequence of impairments of spatial navigation is getting 
lost, an experience we all can relate to. Getting lost can be an early sign of AD and is also a 
common reason for the need for institutionalized care.
17
 Despite the importance of spatial 
navigation, there is no established consensus regarding how to conduct such assessments. 
Brunsdon and colleagues
187
 stated that research on topographical disorientation is hindered by 
factors such as terminological confusion, lack of theoretically driven assessments, and “an 
ongoing failure to examine topographical skills in real-life settings”. The few studies we have 
found that have assessed spatial navigation during walking in patients with cognitive 
impairment have used either route learning tasks in hospital settings
189
 or virtual reality tasks 
conducted on a treadmill.
190
 Much of the knowledge on navigational impairments is therefore 
derived from assessments without the dynamic of movement through environmental settings, 
such as questionnaires or clinical interviews,
191-193
 a human analogue of the Morris water 
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maze test,
194-197
 pencil-and-paper tasks, or being taken through a route learning test in a 
wheelchair.
33;198
 
Studies have reported that approximately 50% of community-dwelling people with AD 
experience navigational impairment,
33;192;199
 and navigational impairments have also been 
reported in patients with mild cognitive impairment (MCI).
33;194;196
 A study of subgroups of 
MCI even found no differences in spatial navigation between persons with amnestic MCI 
(i.e., primarily memory impairments) and persons with AD.
194
 In contrast to studies focusing 
on walking and balance, groups of persons with SCI are also included in studies of spatial 
navigation. Although the sample sizes are low, the results from these studies indicate that 
persons with SCI do not exhibit impaired spatial navigation.
194;195
 However, since most of 
these studies have used outcomes tasks without involvement of walking, the interplay 
between navigational impairments and movement remains largely unexplored in persons with 
cognitive impairment.
35;200;201
 
This interplay between movement and navigation is reported to be important in studies 
involving healthy persons without cognitive impairment. Lövdén and colleagues
201
 studied 
the influence of postural demands on spatial navigation by comparing the performances 
between healthy young and older adults on a VR-based way-finding task while walking on a 
treadmill. In this study the performances of both groups deteriorated when they walked 
without support in comparison to walking while holding the handrails, but the performance of 
the older adults deteriorated the most. These results from Lövdén et al. indicate a dual-task 
effect on way-finding during motor activity in healthy people. This effect was also present in 
a study comparing active (i.e., using a joystick to control their movements in the virtual 
environment) and passive (i.e., watching the virtual environment screen) conditions of a 
virtual reality based wayfinding task, where a detrimental effect of active learning was 
observed.
202
 So, it is likely that a navigational assessment which involves walking may have 
both real-life applicability and also the ability to detect subtle changes in spatial navigation in 
patients with cognitive impairment or dementia. 
4.4 The rationale for this thesis  
Mobility, defined as the ability to move independently and safely from one place to another, 
is a fundamental ability for human life. The existing research has through the use of outcomes 
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mostly suitable for screening purposes established that persons with AD have poorer mobility 
performances than healthy persons at the same age.  
While previous studies generally have treated balance as a unitary construct, we wanted in our 
study to use an outcome that allowed us to target the various aspects of balance in line with 
the systems theory approach. By shifting from global to comprehensive outcomes we aimed 
to expand the knowledge platform on which physical therapists base their interventions. For 
persons with cognitive impairment and AD, safe and independent mobility is however not 
only threatened by impaired balance and walking ability, but also by the loss of the ability to 
determine and maintain a route from one place to another. Spatial navigation is an essential 
skill to participate in activities in society, and there is a need for assessments tools with real-
life applicability that may help to identify persons who may be at risk for getting lost. By 
assessing spatial navigation during walking, we aimed to be able to explore differences in 
navigation between patients at the earliest stages of cognitive impairment. Cognition will also 
be treated as a complex construct, and we will explore the relationship between mobility and 
cognitive domains.  
Although the SCI and the MCI conditions involve persons with heterogeneous backgrounds 
we believe that it is more fruitful to see AD as a continuum rather than as a disease that is 
either absent or present. In this thesis we aim to contribute to a more nuanced understanding 
of the complexity of the mobility construct in persons at possible different stages in the 
continuum of AD. 
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5 Aims of the thesis 
The overall aims of this thesis were to explore how mobility performance differs between 
groups with different levels of cognitive impairment, and to explore the relationship between 
mobility and different domains of cognitive function. The aims of each paper are described 
below: 
 
Paper I:  
- To compare mobility performance between patients with early onset AD and patients 
with other early onset dementias.  
- To explore which variables were associated with the Timed Up and Go test.  
- To examine changes in mobility over one year in patients with early-onset AD.  
Paper II: 
- To explore differences in performance on the BESTest between patients with 
Subjective or Mild Cognitive Impairment, mild AD and moderate AD.  
- To examine which cognitive domains were associated with impaired balance control 
when controlled for demographic and health-related characteristics.   
Paper III: 
- To evaluate differences in spatial navigation between patients with Subjective 
Cognitive Impairment, Mild Cognitive Impairment and mild Alzheimer’s disease.  
- To examine which cognitive tests that are associated with error-free performance on 
the Floor Maze Test.  
28 
 
6 Methods  
6.1 Design  
In all three papers we applied a cross-sectional design; we also applied a one-year 
longitudinal design in paper I. A cross-sectional design is based on data collected at one point 
in time. This design is useful for describing populations, exploring associations and 
generating hypotheses.  
6.2 Recruitment of participants 
In all three papers we recruited participants using a convenience sampling strategy. 
Paper I  
In paper I, the sample consisted of patients with early onset dementia recruited from the 
Memory Clinic in Malmö, Sweden in the period of 2005–2011. Patients were included in two 
sets; the first 28 patients were included either from their first visit to the Memory Clinic, or 
they were included in relation to follow-up appointments. The second 44 patients were 
recruited from a prospective clinical observational study of patients with early onset 
dementia. Inclusion criteria were the same for both sets: they had to be home-dwelling and 
have a mild or moderate degree of early onset dementia. Patients that needed physical 
assistance during the mobility assessment procedure were excluded. 
Paper II  
Participants in paper II were all part of the author’s own data collection at Oslo University 
Hospital (the Memory Clinic at Ullevål and the Geriatric Day Hospital at Aker) and in 
collaboration with the local authority dementia team in Nes. All patients attending the 
Memory Clinic were screened for eligibility by the author who also contacted them (or their 
relatives according to degree of dementia), gave information and set up an appointment if 
they were willing to participate. Patients included at their initial visit to the Memory Clinic 
were also part of the Norwegian Dementia Register (NDR). Others were included while 
attending their yearly follow-up appointments at the Memory Clinic, having prior 
appointments before the NDR was initiated. 
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We also included patients from the NDR at the Geriatric Day Hospital at Aker, but we 
stopped recruitment at this site after a few months because few patients were eligible. In Nes, 
the author and the head nurse of the local dementia team collaboratively screened the patients 
for eligibility. The nurse invited the patients, and the author informed the patients, asked for 
consent, and conducted the formal inclusion. The sample consisted of 137 (80.6%) patients 
from the Memory Clinic, 23 (13.5%) patients from the dementia team in Nes, and 10 (5.9%) 
patients from the Geriatric Day Hospital.  
The inclusion criteria for participants in paper II were (a) home-dwelling, (b) able to walk 
comfortably without walking device, (c) able to communicate in Norwegian, and (d) have a 
tentative diagnose of SCI, MCI or AD. Exclusion criteria were (a) severe stage of AD, (b) 
diagnosis of dementia other than AD, (c) severe hearing or vision impairment, (d) other 
neurological conditions such as stroke with motor symptoms, Parkinson’s disease, or multiple 
sclerosis, or (e) musculoskeletal conditions causing pain that disturbed walking. The inclusion 
period was from January 2011 to August 2012.  
Paper III 
In paper III the sample is almost identical to the sample recruited at the Memory Clinic in 
Oslo in paper II, as we did not carry out the Floor Maze Test at Aker nor in Nes. Since we 
wanted to emphasis the early phases of AD we excluded patients with moderate degree of 
AD. To be able to explore differences between the SCI and the MCI group in performances 
on the Floor Maze Test, we included seven more patients with SCI using purposeful sampling 
strategy during November 2013. A flow chart of the inclusion and exclusion of participants in 
paper II and III is illustrated in Figure 2. 
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Figure 2. Flowchart of the participants involved in papers II and III. 
6.2.1 Diagnostic procedure and categorization of the participants 
The diagnostic process for patients attending the Memory Clinic in Oslo is illustrated in 
Figure 3. This procedure included interviews with both patient and an informant (usually a 
member of family), cognitive testing, neurological, physical and psychiatric examination, 
laboratory tests, and brain imaging.
203
 Additional examination such as spinal fluid analysis 
and assessment by a neuropsychologist, were also conducted when appropriate.  
Some of the patients recruited from the local authority dementia team in Nes had been 
diagnosed at the Memory Clinic at Akershus University Hospital. The remaining patients had 
a structured, but less comprehensive examination by the local dementia team in cooperation 
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with the family doctor. This team consisted of two specially-trained nurses with extensive 
experience in working with patients with dementia. The assessments conducted by the 
dementia team consisted of cognitive testing (MMSE and Clock Drawing Test), evaluation of 
the patient’s ability to perform activities of daily living, and information about burden of care 
for the family. The family doctor supplemented this information with a physical examination, 
blood sample analyses, and referrals to computer tomography  (CT) or magnetic resonance 
imaging (MRI) scans when needed.
204
 In the most complex cases, such as young patients, 
patients with atypical presentations, or unclear etiology, the patients were referred to memory 
clinics.  
The diagnostic procedures were reasonably identical in the memory clinics. Differences were 
related to the cognitive tests used and the criteria applied. In paper I, we used the diagnoses 
set by the staff at the Memory Clinic in Malmø, where the National Institute of Neurological 
and Cognitive Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association 
criteria for AD was applied.
139
 Consensus criteria such as those outlined by Neary et al. for 
frontotemporal lobe dementia
205
 and the McKeith criteria for dementia with Lewy bodies
206
 
were applied. For other diagnoses of dementia such as vascular dementia, criteria from the 4
th
 
edition of the Diagnostic and Statistical Manual of Mental Disorders were applied.
207
 
In papers II and III the participants were invited into the study based on the tentative 
diagnosis made after their first visit to the Memory Clinic. However, these diagnoses may 
have been altered later in the diagnostic process after a weekly consensus meeting (see Figure 
3). To ensure consistent diagnostic evaluation and categorization of the degree of AD in our 
study, an experienced (i.e., more than 30 years of experience) geriatric psychiatrist reviewed 
the diagnoses made at the consensus meeting and categorized the patients as having either 
mild or moderate degree of AD based on all available information. Of the 50 patients with a 
tentative diagnosis of “questionable MCI” after their first visit, 13 were classified as having 
SCI, and 17 were diagnosed with mild degree AD by the psychiatrist. The ICD-10 diagnostic 
criteria for research were used for the diagnosis of AD (see Table 2) and for categorizing 
those with AD as having either mild or moderate degree of AD. To diagnose MCI, we used 
the Winblad criteria (see Table 1).
62
 Persons who, despite their own experience of cognitive 
deterioration, performed within the normal range (less than 1.5 SD below the norm) on the 
cognitive test battery (therefore not filling the criteria for MCI) was assigned to the SCI 
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group.
203
 To reduce the risk of bias, the psychiatrist was blinded to the results of the mobility 
assessments during this diagnosis/categorization process.  
 
Figure 3. Procedure for assessment at the Memory Clinic.203 Reprinted with permission from the 
authors. MMSE-NR: Mini Mental Status Examination – Norwegian revision, TMT: Trail Making Test, COWA: 
Controlled Oral Word Association, MADRS: Montgomery-Aasberg Depression Rating Scale, IQCODE: 
Informant Questionnaire for Cognitive Decline, ADL: Activities of Daily Living, I-ADL: Instrumental ADL, 
NPI: Neuropsychiatric Inventory, MRI: Magnetic Resonance Imaging, SPECT: Single-photon emission 
computed tomography, PET: Positron emission tomography. BPSD: Behavioral and Psychological Symptoms of 
Dementia.  
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6.3 Measurements 
6.3.1 Mobility assessments 
Paper I  
In the Malmø-study all mobility assessments were carried out by the physical therapist who 
worked at the Memory Clinic, and he was therefore not blinded to diagnostic information. 
This therapist had extensive experience with examinations of patients with dementia. The 
assessments were videotaped using a standardized protocol for research purposes. The data 
used in this paper are derived from the videotapes, and timing and scoring was performed by 
the author (blinded to information about diagnoses at this point). In the videos there were 
walking tests that were omitted because of methodological issues.  
Timed Up and Go test: Timed Up and Go was used to assess basic mobility.
208
 The physical 
therapist instructed each patient to rise from the chair, walk at their normal pace to a line 3 m 
away, turn, walk back and sit down again. Timing started when the patient moved their back 
away from the back of the chair and ended when they sat down in the chair again. If the 
patient showed hesitation during the test, the physical therapist repeated the instructions (such 
as “and sit down again”). Both timing and the need for cueing during the test were assessed 
based on the videotapes. The Timed up and Go showed excellent test-retest values (ICC >0.9) 
in two studies of older people with dementia,
209;210
 and a high test-retest value (ICC= 0.76) in 
a study of persons with AD.
211
  
Timed stair walking. A training staircase with handrails and three steps on one side, a 
plateau, and a sloped ramp on the other side was used in this test. The physical therapist 
instructed each patient to walk over the staircase starting with the steps and ending with the 
slope. Timing started when the patient placed a foot on the first step and ended when both feet 
were back on the floor on the other side.  
Timed rising from the floor. In this test the physical therapist instructed each patient to get 
up from lying supine on a soft mat on the floor. Timing started when the patient lifted their 
head from the floor, and ended when they were standing stable in an upright position.  
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Clinical Outcome Variables Scale. This is a functional mobility scale.
212
 In the original 
version each of 13 items is scored by the physical therapist on an ordinal scale from 1 to 7. 
We used only 5 of the 13 items: rolling to the side, supine lying to sitting over the bed edge, 
sitting balance, standing up from lying on the floor, and performance of ambulation. This 
modified version would give a total score ranging from 5 to 35 points, higher scores 
indicating higher levels of independence.  
I have not found any studies of psychometric properties for the last three tests in persons with 
dementia.  
Paper II and III 
In 167 of the 170 patients included in paper II, the author conducted the tests. The remaining 
three were tested by another physical therapist. All the patients included in paper III were 
tested by the author. The assessments were conducted in quiet and undisturbed surroundings 
at all three sites. The author was not blinded to the tentative diagnoses of the participants at 
the time of conducting the mobility assessments.  
Balance Evaluation Systems Test. The Balance Evaluation Systems Test (BESTest) was 
used to assess balance performance in paper II. This test was developed, tested, and published 
by Fay Horak and colleagues in 2009
123
 and thus, it is a relatively new assessment tool for 
evaluating balance. It was developed to identify underlying systems used for balance control, 
consistent with systems theory. Thirty-six items are grouped into six subscales thought to 
reflect the following systems: I. Biomechanical Constraints, II. Stability Limits/Verticality, 
III. Anticipatory Postural Adjustments, IV. Postural Responses, V. Sensory Orientation and 
VI. Stability in Gait. These subscales are described in more detail in Table 4. Each of the 
items is scored by on a 4-point ordinal scale, where 0 is the worst and 3 is the best 
performance. The subscale sums and the total score are converted to percentages (0-100%, 
where 100% is best).  
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Table 4. Descriptions of the subscales in the BESTest
123
  
Subscale Description 
I. Biomechanical 
Constraints 
Strength, flexibility and alignment of posture. 
II. Stability Limits / 
Verticality 
Internal understanding /perception on how far the center of mass can be 
moved beyond the base of support before losing balance and understanding of 
postural upright. 
III. Anticipatory  
Postural Adjustments 
Adjustments made to counteract the forces from voluntary movements. 
IV. Postural 
Responses 
Both in-place and stepping reactions to involuntary displacements of balance, 
such as slips, trips, pushes. 
V. Sensory 
Orientation 
Evaluations of body sway during various alterations of sensory information. 
VI. Stability in Gait Stability during walking under various challenging conditions. One of the 
items is illustrated in Figure 4. 
 
Each patient carried out all tasks barefooted except for the walking tasks in the Stability in 
Gait subscale. It takes up to 30 minutes to complete the 36 tasks in the BESTest. Because we 
aimed to score each patient’s first attempt at each task, we ensured they understood the tasks 
by giving both repeated instructions and demonstrations of how to perform them. Pilot testing 
prior to this study allowed us to anticipate that the three tasks related to compensatory 
stepping responses in subscale IV (Postural Responses) were the most difficult to comprehend 
for our participants (many did not lean sufficiently beyond their stability limits for the first 
attempt). For consistency, we allowed up to three attempts on these three tasks. Other 
deviations from the standard protocol involved the use of verbal cueing for patients that 
hesitated during the timed tasks, and for the Timed up and Go Dual Task (in subscale VI), we 
used the “random numbers” alternative as the cognitive task for all patients. 
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Figure 4. Nurse Mette Vinke demonstrating item 25 in the BESTest: Step over obstacle. 
Photo by Anbjørg Kolaas.  
The BESTest has been translated into Norwegian by a team of physical therapists and 
researchers consistent with recommendations for back-to-back translations. The author was 
part of this team. We used a preliminary version that was almost identical to the final version. 
The original author, Fay Horak, has approved the final version of this translation, but it is not 
yet published because it is part of an ongoing project of a master’s student at the University of 
Oslo. Reliability is not established for the BESTest in persons with cognitive impairment, 
however in samples of older people (without cognitive impairment), high levels of test-retest 
and inter-rater reliability are reported.
123;213
 
Paper III 
The Floor Maze Test. The Floor Maze Test is a test of spatial navigation during walking, 
developed by Sanders and colleagues
214
 in the Einstein Group in New York. We derived the 
size and proportions of the maze from a picture of the Floor Maze Test in the original paper 
(see Figure 5) and created the maze on a dark blue wax cloth with white tape marking the 
lines of the maze.  
37 
 
 
Figure 5. Illustration of the Floor Maze Test.  
 
As each patient was positioned at the entry of the maze, they were instructed with following:  
“You are now at the entry of the maze. The way out is over here (demonstration of exit). You 
are now going to plan how you will walk through the maze while you are standing here. Let 
me know when you have found your way and are ready to start walking“. Instructions were 
repeated when patients asked questions during the test, and they could start over from the 
maze entry if they asked to. Timing was not stopped until they reached the exit of the maze. 
We used one dichotomous variable to indicate whether their walk through the maze was error-
free or with errors, and made three timed measures: 1. Planning Time (time from instruction 
completion to the initiation of walking), 2. Immediate Maze Time (time used to walk through 
the maze, including wrong turns), and 3. Delayed Maze Time (second walk through the maze, 
ten minutes after the first walk). An example of a walk through the maze with errors is 
illustrated in Figure 6.  
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Figure 6. Nurse Mette Vinke demonstrating an error, walking down one of the dead 
ends in the Floor Maze Test. Photo by Anbjørg Kolaas. 
6.3.2 Cognitive assessments 
We used cognitive tests that were incorporated in the test battery of the NDR because we 
aimed to recruit most of our participants from this register. The cognitive tests were therefore 
conducted by any of a number of physicians at the Memory Clinic, by the staff at the Geriatric 
Day Hospital, or by the dementia team. The tests we used are presented in Table 5. 
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Table 5. Overview of cognitive tests used in the three papers 
Cognitive assessment Cognitive domain I II III 
Mini Mental Status Examination Global cognition X X X 
Clock Drawing Test Visuoconstruction  X X 
The Word List Learning Test Memory, learning  X X 
Trail Making Test A Attention  X X 
Trail Making Test B Executive function  X X 
Verbal Fluency Test Language  X  
 
The Mini Mental Status Examination. The Mini Mental Status Examination (MMSE)
215
 
was used  to describe the patients’ level of cognitive function and also as a measure of global 
cognition in all three papers. It is one of the most-used cognitive screening instruments and is 
used worldwide. The test consists of 20 items involving orientation for time and place, 
registration and recall, attention, language, the ability to follow written and verbal commands 
and the ability to copy figures. Scores can range from 0 to 30, where a higher score indicates 
better performance. The MMSE is considered to have adequate test-retest (Pearson r = 0.89) 
and interrater (Pearson r = 0.83) reliability in patients with dementia.
215
 The Norwegian 
version has also proved to be a reliable and valid measure of cognition in persons with 
dementia.
216
 
The Trail Making Test. The Trail Making Test (TMT)
217
 was used in paper II and III. It 
consists of parts A and B, both of which consist of 25 circles spread out on a sheet of paper. 
In part A, the circles enclose numbers that the patient is asked to connect in increasing order 
(1-25). In part B, the circles enclose both numbers (1-13) and letters (A-L), and the patient is 
asked to connect the circles in increasing order, but this time also alternating between 
numbers and letters (1-A-2-B-3, etc.) The tests were stopped after five minutes, however 
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patients that insisted on continuing were allowed one extra minute. The TMT-A was used to 
measure attention and processing speed, and the TMT-B was used to measure executive 
functioning and set-shifting (the ability to go back and forth between multiple tasks). Despite 
the extensive use of the TMT, I have not been able to find information about reliability for 
patients with dementia.  
In paper II we used ordinal scoring to avoid a floor effect related to patients unable to 
complete the test. In so doing, we divided the timed scores into four categories based on 
normative age-adjusted time intervals for both tests
218
: 0, cannot complete; 1, slower than –2 
SD of the norms; 2, between –1 and –2 SDs; and 3, better than –1 SD. In paper III we used 
the timed performance as a continuous measure. To our knowledge, reliability values are not 
established for persons with dementia.  
The Clock Drawing Test. We used the Clock Drawing test in papers II and III to evaluate 
visuoconstructive abilities.
219
 Several variations regarding both procedure and scoring can be 
found for this test. In our case, we gave each patient a piece of paper with a pre-drawn circle 
on it and asked them to draw the numbers so that the circle looks like the face of a clock and 
then to draw the hands of the clock to read 11:10. The 6-point scoring system described by 
Shulman (0-5, where 5 is best) was used in both papers II and III, however in paper III we 
dichotomized this score into 0-4 points vs 5 points. The Clock Drawing Test is considered a 
reliable test in patients with dementia,
219;220
 but the exact ICC values vary depending on the 
version of the test.  
The Word List Learning Test. Also known as “Ten word test” or “Word List learning” from 
the Consortium to Establish a Registry for Alzheimer’s disease (CERAD),221 this test was 
used to evaluate the learning aspect of memory in papers II and III. The word list consists of 
ten unrelated nouns, and each word is written on a card. These cards are presented to the 
patient at two-second intervals, and they read the words out loud to confirm that the word is 
registered. This is repeated twice more, each in a different order. After each trial, the patient is 
asked to recall the words. The outcome is the total numbers of correct words across the three 
trials with a maximum score of 30. Both inter-rater reliability and one-month test-retest 
reliability are substantial for patients with dementia for this test and for the Verbal Fluency 
test.
222
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The Verbal Fluency Test from the CERAD, Animal category. This test was used to assess 
semantic verbal fluency.
221
 Each patient is given 60 seconds to name as many animals as 
possible, and the score is the number of different animals.  
6.3.3 Demographic and clinical information 
The samples in the three papers are described by: age, sex, education, comorbidity, 
employment status, use of medication, ApoE e4 (paper I), walking habits (paper II) and body 
mass index (paper II). In addition to the results of the various cognitive and physical tests, the 
main covariates in the regression analysis were: age, sex, education and comorbidity. Age was 
used as a continuous variable in paper III, and in paper II it was categorized into three groups 
(51-69 years, 70-79 years and 80-92 years). Comorbidity was used as a dichotomous variable 
(yes or no) in the regression analysis in all three papers. In paper I we based this 
dichotomization on information derived from the medical records. In papers II and III we 
used information from the medical records and the NDR, but also asked this direct question to 
the patient and informant: “Do you have any injury or condition, such as arthritis, hip 
prosthesis or previous fractures that may affect your balance?”  
6.4 Statistical analyses 
The statistical analyses in paper I were performed using PASW Statistics 18.0 (SPSS Inc., 
Chicago, IL., USA), while in papers II and III we used IBM SPSS Statistics version 20 (IBM 
Corp, Armonk, New York).  
In all three papers we presented the results of continuous variables with normal distribution 
using means and standard deviations, continuous variables with skewed distributions using 
medians and interquartile ranges (or by 1
st
 and 3
rd
 quartile), and categorical variables using 
numbers and percentages. Parametric statistics were used when variables were normally 
distributed, and non-parametric statistics are used for variables with skewed distribution and 
categorical variables. We used a 5 % level of significance for all analyses, unless otherwise is 
explicitly stated. All statistical tests were 2-tailed. Descriptive analyses were carried out in all 
three papers; however we present only the main statistical methods used to analyze the 
research questions in the section below. We used Cohens
223
 proposed guidelines for 
interpretation of effect sizes.   
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Multiple regression analyses 
In all three papers we conducted multiple regression analyses to explore associations between 
mobility outcomes as dependent variables and demographic variables and cognitive tests as 
independent variables. Despite some differences in building the models, there were several 
elements consistent across these analyses that we would like to mention. The first concerns 
choice of independent variables, which in all three papers was based mainly on clinical 
reasoning and where relevant also on results from previous studies. We examined the 
bivariate correlations between each of the independent variables to check for cases of 
collinearity (defined in the present analyses as a correlation coefficient greater than 0.7); 
however, we did not exclude any variable based on such findings. Furthermore, we have 
carefully inspected the residual plots for outliers and deviations from normal distributions to 
assure that the model assumptions were not violated.  
Several procedures to perform a multiple linear regression analysis exist. Based on the 
explorative character of our research questions, we decided to use the backward removal 
approach in the analyses reported in all three papers. Using this approach, we first entered all 
the independent variables into the model, and then excluded the variable with the smallest 
contribution (largest P value). We continued in this way, until we had only variables that were 
significantly associated with the dependent variable. The only exception for this procedure 
was made in paper II, where we wanted to explore the associations between the BESTest 
scales and the cognitive tests while adjusting for demographic factors. We therefore decided 
to enter our independent variables in two blocks; the first block contained the demographic 
factors and the second block contained the cognitive tests. The first block was kept in the 
model throughout the entire analysis, while we used the backward removal approach on the 
variables in the second block. Final models are presented with adjusted explained variance, 
which crudely assess how well the model fits the data. All regression coefficients in these 
analyses are represented by the unstandardized B, which represents the slope of the regression 
line (the amount of change in the dependent variable Y resulting from a change of 1 unit of  
the independent variable X, while statistically controlling for the other independent 
variables).
224
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Table 6. An overview of the statistical analysis used in the three papers 
Statistics Paper I Paper II Paper III 
Statistical analysis of differences 
Exploring within-group differences: 
Paired t test 
McNemar test 
Exploring between-group differences: 
Chi-square test 
Mann-Whitney test 
Univariate analysis of variance 
2-way between-groups analysis of variance 
Kruskal-Wallis test 
 
 
X 
X 
 
X 
 
X 
 
 
 
 
 
 
 
 
 
 
X 
X 
 
 
 
 
 
X 
X 
 
 
 
Statistical analysis of relationships 
Exploring relationships: 
Correlations (Pearson r and Spearman’s rs) 
Multiple regression analysis 
 
 
X 
X 
 
 
X 
X 
 
 
X 
X 
 
Table 6 shows the analyses we used to analyze the main research questions in the three 
papers. In addition, some comments related to these analyses are provided below.  
Comments to the analyses in paper I: In the univariate analysis of variance, where we 
compared performances on the mobility outcomes between the groups of early-onset AD and 
early-onset other dementia while controlling for sex, we used a 1% level of significance 
because the assumption of homogeneity of variance was violated.  
Comments to the analyses in paper II: To compare performances on the BESTest scales 
between the three groups, we conducted two-way analysis of variance between groups where 
we controlled for age. When the main effects were significant, we also performed Bonferroni 
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post hoc comparisons to identify the pairwise differences, and at the same time adjusting for 
multiple comparisons. 
Comments to the analyses in paper III: In the multiple regressions analyses, we log-
transformed the skewed dependent variables and back-transformed the regression coefficients 
and confidence intervals using the formula [exp(estimate) - 1] x 100 %, thus reporting 
percentages.  
Sample sizes  
The data used in the study of patients with early-onset dementia presented in paper I were 
collected before we became involved in the study. Therefore, we did not make sample size 
calculations for this study. 
When we planned the study presented in papers II and III, we made a sample estimate based 
on gait speed which we initially thought would be our main outcome. We used the 
recommendations for meaningful change (0.1 m/s) and estimated SD (0.15-0.16 m/s) from a 
study including both community-dwelling older people and sub-acute stroke patients (n = 
200).
225
 The sample size was calculated with a power of 80% and a significance level of 5%, 
which suggests that we would need 42 persons in each of the three groups. Because of 
concern of enough power for other outcomes we decided to increase the sample size by 20%, 
to 50 persons in each group. As a general rule, for the multiple regression analyses, we aimed 
to have at least 10 persons for each independent variable.
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We did not achieve the desired sample size in each of the three groups. Implications of this 
will be addressed in the discussion section. In paper II we made a post-hoc power analysis for 
the multiple regression analyses to ensure that we had a sufficient number of patients in 
relation to the independent variables we wanted to include in the analysis. Based on 11 
independent variables, a power level of 0.80, a significance level of 5%  and the lowest 
observed R
2 
(0.20), we would need 78 patients in the regression analysis. An R
2 
of 0.20 equals 
moderate to large effect size (R
2
/(1- R
2
)).
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For paper III  we estimated that to be able to detect a large effect size (>0.35) with 80% 
power, a significance level of 0.05 and nine independent variables, we would need a sample  
of at least 54 patients in the regression analysis.  
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6.5 Ethical considerations 
All patients gave their informed written consent to participate in both studies. The study in 
paper I was approved by the Internal Board of Ethics at Skåne University Hospital. The study 
in papers II and III was approved by the Regional Committee for Medical and Health 
Research Ethics in the South East of Norway and also by the Oslo University Hospital’s 
Privacy and Data Protection Officer.  
To include patients with cognitive impairment in research is a delicate issue. To be able to 
consent to participate, it is required that the information about the project is understandable 
for each individual. The standardized formal information and consent forms provide a level of 
information that may compromise the availability of any reader regardless of cognitive 
impairment. Because we included patients with very different degrees of cognitive 
impairment, we tailored the information toward each patient’s level of impairment. To 
achieve this, we tried to give the patients, and their family member when appropriate, 
sufficient oral information as well. We focused on three key issues: the purpose of the study 
and what kind of assessment they were going to participate in, that participation was 
voluntary and a decline would have no consequences for the patient’s continuing health care, 
and that we would assure that the routines for keeping their information unavailable to 
persons outside the project was followed. We invited only those patients whom we felt had 
comprehended these issues.   
Most patients were invited by telephone. Those with the lowest MMSE scores were discussed 
with the nurse who knew the patient to determine if the patient were able to respond to such a 
call. We contacted a family member when the nurse or the medical record indicated this 
necessity. When in doubt, we sought to ask the patient in person during their ordinary visits to 
the Memory Clinic.  
To ensure the patients were not injured during the assessment sessions the physical therapists 
were prepared to provide support if a patient was about to fall. There were no falls or injuries 
in relation to these assessments.   
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7 Main results 
In this section we present the characteristics of the participants in the three papers (Table 7), 
and the main findings from each of the studies. More comprehensive presentations of the 
results are given in papers I, II, and III.  
Table 7. Characteristics of the participants included in papers I, II, and III 
 
Paper I 
(n = 72) 
Paper II 
(n = 170) 
Paper III 
(n = 128) 
Age, mean (SD) 60.9 (4.1) 72.4 (9.1) 69.8 (8.1) 
Men, n (%) 34 (47.2%) 85 (50%) 69 (53.9%) 
Years of education, mean (SD) 10.7 (2.4) 12.7 (3.6) 13.9 (3.4) 
Work-related status, n (%) 
Working 
Sick leave/disability benefit 
Retired 
Other 
Missing 
 
15 (20.8%) 
28 (38.9%) 
14 (19.4%) 
7 (9.7%) 
8 (11.1%) 
 
22 (12.9%) 
24 (14.1%) 
117 (68.8%) 
7 (4.2%) 
0 
 
21 (16.4%) 
20 (15.6%) 
83 (64.8%) 
4 (3.1%) 
0 
Use of cholinesterase inhibitors, n (%) 42 (58.3%) 51 (31.1%) 28 (22.2%) 
Mini Mental Status Examination, median (IQR) 21.5 (6) 25.0 (6) 26.0 (4) 
  
The participants in paper I were significantly younger, had less education, and lower MMSE 
scores (p<0.001 for each) than the participants in paper II. If we exclude the participants with 
SCI and MCI from the sample in paper II, the differences still remain significant at p<0.001. 
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7.1 Paper I 
Differences in mobility between persons with AD and other dementias 
The first aim of this study was to compare mobility performances among patients with early 
onset AD and patients with other types of early onset dementia. The patients with early onset 
AD performed significantly better than those with other dementias on all measures of 
mobility: Timed up and Go (P = 0.003), timed stair walking, timed rise from floor and 
modified Clinical Outcome Variables Scale (P < 0.001 for each). There was no difference 
between the groups regarding the need for cueing during the performance of Timed up and 
Go test (P = 0.82).  
Associations between Timed Up and Go and independent variables 
A second aim of the study was to explore which variables were related to Timed up and Go in 
a multiple regression analysis. The independent variables in this analysis were diagnostic 
group, MMSE score, sex, education and comorbidity. After a backward removal procedure, 
we found that the diagnostic group variable (AD vs other dementia) was the only variable 
independently associated with time on Timed Up and Go (B = -3.7, 95% CI –5.7 to –1.8, P < 
0.01). This indicated that having a diagnosis other than AD increased the time on the Timed 
Up and Go test by 3.7 s. The adjusted explained variance of the final model was 0.23.  
Changes in mobility at the one-year follow-up of patients with AD 
The last and primary aim of the study was to examine the changes in mobility over a one-year 
period in the patients with AD, and we re-examined 25 patients with AD one year after 
baseline assessments. The performances on the Timed up and Go (P = 0.028) and the timed 
stair walking (P = 0.02) were significantly worse at the one-year follow-up. The differences 
on Timed Up and Go are illustrated in Figure 7. The need for cueing during this test was 
unchanged from baseline to follow-up (P = 1.0). The changes in timed rise from floor (P = 
0.56) and the modified Clinical Outcome Variables Scale (P = 0.48) were not statistically 
significant.  
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In conclusion we found that the patients with early onset AD had better performances than 
those with other early onset dementia on all mobility tests. However, mobility performances 
got slightly worse between baseline and the one-year follow-up in the group of early onset 
AD patients.  
 
Figure 7. Illustration of the differences in performance on the Timed Up and Go between 
baseline and the one-year follow-up plotted against the time at baseline for the 25 patients 
with early onset AD. No difference between baseline and follow-up is indicated by the 
horizontal line. Copyright © 2012 Karger Publishers, Basel, Switzerland.  
7.2 Paper II  
Differences in the various aspects of balance between the SCI/MCI, mild AD and moderate 
AD groups 
The first aim of this study was to compare the performances on the BESTest between the 
three groups with different levels of cognitive impairment: SCI/MCI, mild AD, and moderate 
AD. Mean scores and confidence intervals for the subscales are illustrated in Figure 8. The 
performances of the three groups were significantly different from each other, adjusted for 
age, on all the subscales and also on the total score of the BESTest (P = 0.005 to <0.001). The 
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mild AD group performed worse than the SCI/MCI group, but better than the group with 
moderate AD. We found large effect sizes of the group differences on the total score (ηp
2 
= 
0.24) and subscales Stability in Gait (ηp
2 = 0.27) and Anticipatory Postural Adjustments (ηp
2 
= 
0.18). The between-group differences on the other subscales had medium effect sizes (ηp
2
 = 
0.07-0.10). 
Associations between the various aspects of balance and cognitive domains  
The second aim of this study was to examine which cognitive tests were related to the 
different aspects of balance, and we performed multiple regression analyses with each of the 
BESTest subscales as dependent variables. The subset with a complete dataset for the 
regression analyses consisted of 111 (65.3%) patients. These patients were younger and had 
better MMSE scores than those excluded from the regression analysis because of missing 
data.  
Independent variables in the regression analysis were demographic variables age, sex, 
education, comorbidity and walking habits, and cognitive tests MMSE, Word List Learning 
test, Clock Drawing Test, Verbal Fluency Test, and TMT A and B. The TMT B was 
significantly associated with each of the BESTest scales (P = 0.017 ‒ <0.001). The only other 
cognitive test that was significantly associated with any of the BESTest scales was the Verbal 
Fluency Test which remained in the final model of the Stability in Gait subscale (P = 0.01).  
Among the demographic factors age contributed to all the final models, sex was in the final 
model of Anticipatory Postural Adjustments and Total Score, and comorbidity contributed to 
the final models of Biomechanical Constraints, Anticipatory Postural Adjustments, Sensory 
Orientation, Stability in Gait, and Total Score. Education and walking habits were not 
independently associated with any of the BESTest scales.  
The explained variances of the final models ranged from 0.20 for the Sensory Orientation 
subscale to 0.64 for the Total Score. In effect size terms, this corresponds to medium effect 
size (f 
2
 = 0.32) for the Sensory Orientation subscale and large effect sizes (f 
2
 = 0.54-1.22) for 
the Total Score and the other subscales.  
In conclusion, we found differences in all measured aspects of balance between each of the 
groups, with the lowest scores in the group with moderate AD. All aspects of balance were 
associated with executive function.  
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Figure 8. Mean score and 95 % confidence intervals for the six subscales of the Balance 
Evaluations Systems Test (BESTest) for the groups of subjective or mild cognitive 
impairment, mild Alzheimer’s disease and moderate Alzheimer’s disease. Higher score 
indicates better performance. Reprinted from Phys Ther. 2014;94(8):1123-1134, with 
permission of the American Physical Therapy Association. Copyright© 2014 American 
Physical Therapy Association.  
Additional analyses: Associations between the various aspects of balance and 
cognitive domains 
After publication we discovered that we had a flaw in the regression analyses in paper II. The 
flaw concerns the independent variables TMT A and B, and the Clock Drawing Test. The data 
we used from the NDR are ordinal versions of these tests; however, we forgot to create 
dummy variables before entering them in the regression models. Therefore, to examine if this 
51 
 
flaw had influenced the results, we re-analyzed the regression analyses using TMT A and B as 
continuous variables, and the Clock Drawing Test as a dichotomous variable (same cut off as 
in paper III). The final models from these analyses are presented in Table 8.  
Table 8. Associations between the Balance Evaluation Systems Test and cognitive 
assessments, adjusted for demographic factors (n= 79) 
 I. Biomechanical Constraints II. Stability Limits 
B
a 
95% CI P Adj. R
2 b
 B
a
 95% CI P Adj. R
2 b
 
Trail Making Test A     -0.04 -0.07, -0.02 0.003 0.31 
Trail Making Test B -0.05 -0.09, -0.01 0.016 0.37     
 III. Anticipatory Postural Adjustments IV. Postural Responses 
B
a 
95% CI P Adj. R
2 b
 B
a
 95% CI P Adj. R
2 b
 
Trail Making Test B -0.04 -0.07, -0.004 0.028 0.38 -0.05 -0.09, -0.02 0.005 0.33 
 V. Sensory Orientation VI. Stability in Gait 
B
a
 95% CI P Adj. R
2 b
 B
a
 95% CI P Adj. R
2 b
 
Verbal Fluency Test     0.71 0.099, 1.32 0.023  
Trail Making Test B -0.05 -0.09, -0.02 0.004 0.23 -0.05 -0.09, -0.01 0.022 0.45 
 Total Score 
 B
a
 95% CI P Adj. R
2 b
  
Trail Making Test B -0.04  <0.001 0.55  
a
Unstandardized Coefficient, 
b
The R
2 
value for the entire model including demographic 
factors 
7.3 Paper III  
Differences in spatial navigation between the SCI, MCI and the mild AD group  
The first aim in paper III was to explore the differences in spatial navigation between patients 
with SCI, MCI and mild AD. We found that patients with SCI were faster than those with 
MCI on all the three components of the Floor Maze Test: Planning Time (P = 0.013), 
Immediate Maze Time (P = 0.021) and Delayed Maze Time (P = 0.031). There were no 
statistical significant differences in Planning Time (P = 0.57) or Immediate Maze Time (P = 
0.12) between patients with MCI and those with mild AD. However, the patients with MCI 
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were faster than the patients with mild AD on the Delayed Maze Time (P = 0.02), and they 
had also a higher proportion of error-free performance on the Immediate Maze Time (P = 
0.007) than the mild AD patients.  
 
Figure 9. Box plots showing the median, interquartile ranges, and outliers for the Immediate 
Maze Time component of the Floor Maze Test.  
Associations between spatial navigation, demographic factors and cognitive domains 
The second aim of this paper was to explore which of the demographic factors and cognitive 
tests were associated with performance on the three components of the Floor Maze Test. The 
patients included in the regression analysis had higher levels of education (P = 0.03) and 
better MMSE scores (P < 0.001) than the patients who were excluded from this analysis 
because they had missing data or were unable to complete the Floor Maze Test. 
In the regression analysis we log-transformed the Floor Maze Test components because of 
their skewed distributions (see Figure 9). We included these demographic variables: age, sex, 
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education and gait speed. The cognitive tests included as independent variables were MMSE, 
Word List Learning Test, Clock Drawing Test and TMT A and B. Planning Time was 
associated only with the MMSE score (B = -6.4, 95% CI 12.3, -0.1, P = 0.049), and the 
adjusted explained variance was 0.04. Immediate Maze Time was significantly associated 
with the TMT B (B = 0.4, 95% CI 0.3, 0.6, P < 0.001), and the adjusted explained variance 
was 0.23. The final model of the Delayed Maze Time consisted of the TMT B (B = 0.4, 95% 
CI 0.2, 0.6, P <0.001) and the Word List Learning test (B = -3.6, 95% CI -6.5, -0.6, P = 
0.018), and the adjusted explained variance was 0.31. None of the sociodemographic factors 
were independently associated with any of the three Floor Maze Test components.  
The B-coefficient of 0.4 % indicates that if the performance on the TMT B increased by 10 
seconds, the corresponding change in the Immediate Maze Time would be 4%. The estimated 
effect size [f 
2
 = R
2
 / (1 − R2)] of the multiple regression model was small for the Planning 
Time (f 
2
 = 0.12) while for the Immediate Maze Time and Delayed Maze Time they were 
large
227
 (f 
2
 = 0.41 and f 
2
 = 0.56, respectively).  
In conclusion, we found differences in the performances between the SCI and MCI groups 
and between the MCI and the mild AD groups, with worse performances in the group with 
more severe cognitive impairment. Executive function was associated with the Floor Maze 
Test, but explained variances were low. None of the demographic factors were associated 
with the Floor Maze Test.  
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8 Discussion 
In this chapter, methodological issues regarding the internal and external validity of the study 
will be discussed first and will be followed by a general discussion of the main findings in the 
light of recent literature across each of the separate papers. Detailed discussion on findings 
and methodological issues regarding each of the separate research questions from each paper 
will not be addressed in this part, as this is covered in the individual papers.  
8.1 Discussion of methodological issues 
8.1.1 Internal validity 
Design  
In all three papers we have applied a cross-sectional design, which in general is suitable to 
describe a sample at one point in time and to examine associations between variables. This 
may serve as a foundation to plan for longitudinal studies or intervention studies.
224;226
 
We compared mobility between groups of increasing severity of cognitive impairment, which 
may be regarded as an attempt to simulate a trajectory of mobility decline in the continuum of 
AD. To achieve this we should ideally have applied a longitudinal design where we followed 
the same sample of patients for years. There are however also those who argue that cross-
sectional studies may be used to shed light about processes (i.e., mobility decline) evolving 
over time by measuring this process at different points in its evolution with different stages 
(i.e., of cognitive impairment).
224
 To be able to infer our findings in this perspective there 
should be no other possible explanations besides the difference in cognitive group responsible 
for the differences we have observed in mobility. The heterogeneous character of patients 
categorized as having SCI and MCI, where a large proportion probably never will develop 
AD, makes it very difficult to infer findings related to these groups into a “change over time” 
perspective. This is also the case in our study, and we cannot claim that our findings of 
between-group differences show a decline in mobility.  
However, given the enormous effort needed to conduct a longitudinal study, in terms of both 
numbers of participants and length of follow-up, to investigate the decline in mobility 
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covering the same range of cognitive impairment, knowledge derived from cross-sectional 
studies are still valuable. In line with the stated aims of this thesis—to explore between group 
differences in mobility, and to explore the relationship between cognitive domains and 
mobility—the cross-sectional design is suitable. However, in order to draw valid conclusions 
from our cross-sectional studies, special attention needs to be paid to the issues of group 
assignments and assessor blinding. 
The group assignments are based on clinical judgment and it is therefore important to limit 
the sources of variation in this part of the study. To ensure consistency in the group 
assignments, this work was performed by an experienced geriatric psychiatrist who was 
blinded to the results from the mobility assessments. Several patients with a tentative 
diagnosis of MCI after the initial visit to the Memory Clinic were instead assigned to the mild 
AD or the SCI groups in our study. None of the patients diagnosed with AD were assigned to 
another group during this process, which is probably because the clinicians refrain from 
setting the diagnosis of AD until they are as certain as can be; AD is after all a progressive 
disease without a cure at the moment. We believe that the thorough work with the group 
assignments provides trust in valid and consistent categorization of our participants. 
The blinding of the psychiatrist in the diagnostic work is particularly important for internal 
validity given that the physical therapists were not blinded for the patients’ tentative 
diagnoses at inclusion and during the assessments. Information about the tentative diagnoses 
may have inferred bias by making the physical therapists prone to score the patients’ 
performance accordingly to the degree of cognitive impairment. This risk of bias was reduced 
by the many patients with tentative MCI being assigned to either the SCI or the mild AD 
group. For the seven extra patients with SCI we recruited during November 2013 the risk of 
bias is clearly present, since these patients were recruited with the purpose to have the equal 
number of participants in the SCI group as in the MCI group. This sampling strategy may 
have reduced the internal validity; however, the observed differences are also statistically 
significant without these seven extra patients with SCI.  
In paper I, the mobility assessments were part of the daily clinical routine at the Memory 
Clinic in Malmø, and the physical therapist who instructed the patients was not blinded to the 
diagnostic information available at the time of these assessments. However, this lack of 
blinding will have little influence given that the author used the video recordings from these 
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assessments to time and evaluate the mobility outcomes for the purpose of this study. Also, 
the author was blinded to diagnostic information during the work with these video recordings.   
So, lack of blinding of the physical therapists who conducted the assessments for tentative 
diagnoses pose a threat to the internal validity; however, the potential influence is not critical 
given the blinding of the psychiatrist who conducted the group assignments in papers II and 
III and blinding of the author who rated and timed the performances in paper I.  
Outcome measures   
In paper I we used several timed performance-based tasks, such as walking over a staircase, 
rising from the floor, and the Timed Up and Go test. These tasks are characterized by moving 
from one place to another which is in line with the definition of mobility, and I believe that 
both the construct validity and the face validity should be satisfactory for these tasks.  
The main outcome measures of papers II and III, the BESTest and the Floor Maze Test, are 
both rather novel tests, and the different aspects of validity of the tests are not yet properly 
established. Our aim in paper II was to explore balance in line with the understanding of the 
systems theory, and the BESTest was therefore the obvious choice since it is developed  based 
on the systems theory.
123
 There are currently no factor analyses that have confirmed the six 
subscales of the BESTest as separate constructs/entities, so the content validity is not 
confirmed with regard to its theoretical foundation. However, it is important to remember that 
in systems theory the subsystems of balance are regarded as inter-related,
1;123
 and I believe 
that it is likely to expect a substantial amount of overlapping information from the subscales. 
The moderate to large (rs between 0.5 -0.7) correlations between the subscales indicate that 
we have examined separate but related balance abilities. The comprehensiveness of the 
BESTest was confirmed in a study where the content of several balance scales were 
compared, and the BESTest showed the greatest breadth of content based on the International 
Classification of Function.
228
 So, despite that the validity of the BESTest has not been 
properly established in populations with cognitive impairment and dementia, it still appears to 
be a suitable tool for our purpose to assess a range of different aspects of balance.  
The Floor Maze Test has only been used in one published study so far in which a large sample 
of cognitive healthy persons in the US was included. The test was developed as a clinical test 
of exocentric navigation for this study.
214
 The low correlation (r = 0.299) between the Floor 
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Maze Test and a paper-and-pencil maze in this original paper suggests that solving a task on 
paper is conceptually different from solving the approximately same task while walking. 
However, there has not been any attempt to validate the Floor Maze Test against real-life 
spatial navigation so far, and there is also a lack of a gold standard measure in this field. 
Getting lost is of course the ultimate failure of spatial navigation; however, it is desirable to 
be able to detect and monitor more subtle changes in spatial navigation in order to be able to 
identify persons at risk before the impairments become so pronounced that the person gets 
lost. We were able to detect differences between the SCI and the MCI group in our study, so 
the Floor Maze Test appears to be a sensitive outcome measure. However, validation against 
real-life navigational performance remains to be established, and our results should be 
interpreted with this in mind.   
We aimed to use tests that were suitable in the clinical settings where we conducted our 
studies, which imply that the tests should not require expensive or advanced equipment, and 
they should be accepted by the patients. Besides the four patients we excluded (Figure 2), the 
remaining patients completed the assessments without any overt lack of motivation or effort 
to complete the tasks they were given. This may be attributed to acceptable face validity of 
the tests. The performance-based tests in all three papers turned out to be both feasible and 
well tolerated in our sample of patients with cognitive impairment. 
The validity of our outcome measures is also reliant on satisfactory reliability properties. The 
reliability of performance-based outcomes depends on the patients’ ability and motivation to 
understand and carry out the tasks they are given. It is not self-evident that patients with 
dementia are able to meet such requirements, and many studies have excluded persons with 
cognitive impairment from reliability studies of performance-based tests. The Timed Up and 
Go test is the only one of the mobility outcome measures, that has been examined for 
reliability properties in persons with dementia,
229;230
 which may be considered as a limitation 
of our study. However, in the last decade several studies have investigated the reliability of 
several performance-based measures in patients with dementia, and overall they seem to be as 
reliable as in other populations.
209;210;231
 Also, the patients we examined had a milder degree 
of cognitive impairment than patients involved in previous reliability studies. Thus, I think it 
is fair to assume that the reliability of the outcomes used in our studies do not deviate too 
much from the findings in studies of samples without cognitive impairment.  
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Statistical analyses 
Last but not least, I will comment on the implications of some issues related to the statistical 
analyses in our studies, including accuracy of results, missing data, and sample size issues.  
Accuracy of results 
In paper II we had a flaw across all the regression analyses caused by incorrect use of ordinal 
variables as continuous variables in the analyses. However, in the re-analyses of the 
regression models (Figure 8) the results remain largely unchanged. An exception was the final 
model of subscale II Stability Limits, where TMT A was the only variable in the final model 
instead of TMT B in the published results. The explained variances tended to be around 5% 
lower compared to the published values in paper II. Overall, the conclusion is still that 
executive function, measured by the TMT-B, is the most important cognitive domain for 
balance. The downside is of course that the sample involved in the regression analysis is then 
smaller (n= 79) as the patients that were unable to complete the TMT-B are omitted from the 
analyses due to missing data.  
Missing data 
We have missing data related to the cognitive tests that we use as independent variables in the 
multiple regression analysis in papers II and III. There are several possible approaches to 
handling issues with missing data, and they are chosen depending on the extent and patterning 
of the missing values. In cases where data are missing at random and not to a large extent, 
there is the possibility to substitute missing values with values that represent the “best 
guess”.224 However, in our study, we had most missing data in the patients with the most 
severe cognitive impairment; thus, they were not random. Therefore, we did not consider to 
substitute the missing data in any way, and instead we chose to exclude the patients with 
missing data from the regression analyses. Missing data on the TMT-B is not the case only for 
our study. McGough et al.
232
 reported that 10.8% of participants with MCI were unable to 
complete the TMT-B within the 300 seconds time frame. Ashendorf and colleagues
233
 
reported that 15.4% of a sample of healthy elderly, MCI, and AD were unable to complete the 
TMT-B, mostly related to degree of cognitive impairment.  
The amount of missing data could perhaps have been less if we conducted additional 
cognitive tests in relation to inclusion in our study. However, cognitive testing is demanding 
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and tiring for persons with cognitive impairment. Prior to the study we had therefore decided 
not to perform additional cognitive testing of the patients in order not to interfere with the 
clinical practice at the Memory Clinic. We figured that too many cognitive test sessions may 
lead to reduced willingness to attend the routine control appointments that they were more 
dependent on and may also lead to reduced willingness to participate in our study. The 
consequence is that we have to limit the generalization of our results from the multiple 
regression analysis to populations with a milder degree of cognitive impairment. 
Sample size issues 
We were not able to include 50 patients in each group as we originally planned for in the 
study in Oslo. Small samples increase the risk of making type II errors. A type II error refers 
to the failure to reject a false null hypothesis.
226
 However, both in paper II and paper III we 
were able to reject our null hypothesis that there were no differences between the groups, 
which relate to the rather large effect sizes of the between-group differences. Also in paper I 
we have small samples; however, we found consistent differences between the groups of AD 
and other dementia, and we also detected decline in mobility performances in the one year 
follow-up of the AD group. I therefore think that the small samples in our studies did not lead 
to type II errors.  
A consequence of the missing data in one or several of the cognitive tests in our study in Oslo 
was that we had relatively fewer patients in the multiple regression analysis in papers II and 
III than in the between-group analyses. There are several approaches to determine the 
necessary sample size in relation to the number of independent variables of interest. 
Altman
226
suggests two general rules for determining how many independent variables a 
model may include such as n/10 where n is the sample size, or to use the square root of the 
sample size. We used these rules beforehand to briefly check if we had the sufficient number 
of patients related to the variables we wanted to include in our model. Then after performing 
the analyses we made post hoc analyses based on the effect sizes of the regression models. 
Since our models had in general rather large effect sizes, we were able to conclude that we 
had a sufficient number of participants in relation to the number of independent variables. 
However, we would not have been able to detect small effects in these models. Besides the 
risk of type II errors, small samples also imply that we have to be careful when we interpret 
the results in relation to a more general population which will be addressed in the discussion 
of the external validity.  
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8.1.2 External validity 
The external validity of a study relates to whom, in what setting, and at what times the results 
can be generalized.
234
 Threats to the external validity are peculiarities of the research setting, 
biased selection process of participants, small sample sizes, and unsatisfactory internal 
validity.  
The research setting in all three papers are predominantly memory clinics, although we in 
paper II included some patients through a local authority dementia team. Given that the 
memory clinics do not have the capacity to carry out the diagnostic work for all persons with 
suspected dementia in the community, their prioritizations influence to whom we may 
generalize our results. The memory clinics prioritize patients that are home-dwelling, young, 
and with diffuse symptoms. For the study in paper I concerning patients with early onset 
dementia, this is of course a strength. The Memory Clinic in Malmø has even the regional 
responsibility, with exception for persons with suspected frontotemporal lobe dementia, for 
diagnostics assessment of persons younger than 65 years. In the Oslo study we aimed to 
compensate for the rather young, urban and less cognitively impaired sample at the Memory 
Clinic by also including patients from the Geriatric Day Hospital at Aker and from the local 
authority dementia team in a rural community in Nes. At Aker there were fewer eligible 
patients than expected, so we ended the effort to include patients from this site. In Nes, 
however, we were able to include about 20 patients to complement our memory clinic sample. 
Together, our sample in papers II and III had a wide age distribution and also represented 
patients from both urban and rural communities.  
The selection process itself is largely determined by the choice of inclusion and exclusion 
criteria. In both the Oslo and the Malmø study we included only patients that were home-
dwelling and able to walk without noticeable pain or the use of a walking device, which is 
very much in line with the characteristics of the memory clinic patients in general. In the 
longitudinal part of the study in paper I, only 25 of the 42 (60%) patients with AD attended 
the follow-up assessment after one year. Although we have no complete information about the 
reasons for not attending, it is likely that it was the well-functioning patients that were 
retested, since the main reason for not attending the follow-up was admission to a nursing 
home. Based on this information we suggest that our findings from paper I can be generalized 
to home-dwelling, ambulatory persons with early onset dementia (other than persons with 
frontotemporal lobe dementia).  
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In the study described in papers II and III we consecutively screened all patients that attended 
the Memory Clinic for suitability according to our inclusion and exclusion criteria. Only 27 
out of the 208 patients (13%) who were invited to participate declined our invitation (Figure 
2). High participation rate is one of the advantages of a cross-sectional design since it is less 
demanding to participate in a study that only involves one test session than to oblige oneself 
to longitudinal studies or intervention studies. The high level of participation contributes to 
confidence in the generalizability of our sample. However, in general our results from papers 
II and III are most likely to be generalizable to independently ambulatory, home-dwelling 
persons with a mild degree of cognitive impairment and AD. 
In relation to generalizability, special attention has to be paid to the SCI group. As mentioned 
in the introduction, the SCI condition represents a heterogeneous group of patients that are 
concerned about their memory related to systemic, neurologic, or psychiatric diseases, to 
psychological strains such as sorrow or work-related stress, or in several cases they may also 
be concerned for their own cognitive health because they have close relatives with dementia. 
But according to previous research, the SCI condition represents a high-risk state for future 
development, and some of them will be in a preclinical stage of dementia, in most cases 
AD.
45;47
 The characteristics of groups with SCI are likely to vary between studies, given the 
lack of well-defined criteria. In our study this group is quite small, which also reduced the 
generalizability. Then, on the other hand it is important to gain more knowledge about this 
group, as patients classified as SCI are frequently attending the memory clinics.
203
 After all, 
these patients are so concerned that their family doctor has referred them to a memory clinic. 
In our group, the level of education was high (mean 14.8 years of education) which may also 
explain why they were still able to perform within the normal range of scores on the standard 
cognitive test batteries.
47
  
To sum up the discussion of the methodological issues, the internal validity seems acceptable 
in the three papers, and the findings may be generalized to home-dwelling, ambulatory 
persons attending outpatient specialist health services for dementia assessment.  
8.2 Discussion of results 
In this thesis we examined how mobility performance in terms of balance and spatial 
navigation differed between groups with different levels of cognitive impairment, and we also 
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explored the relationship between mobility and different domains of cognitive function. The 
overarching goal of the thesis was to provide useful information to design interventions aimed 
at enabling persons with cognitive impairment and dementia to maintain their ability of 
independent mobility for as long as possible. The main findings across the three papers will 
be discussed, and I will address how these findings may help to direct future interventions.  
8.2.1 Relationship between mobility and severity of cognitive 
impairment 
In our studies we found differences in mobility regarding both balance and spatial navigation 
during walking between groups of patients with different degrees of cognitive impairment. In 
all the comparisons we made, these differences were characterized by worse performance in 
the group exhibiting the most pronounced cognitive impairment. These cross-sectional 
findings are supported by the decline in mobility we observed in the one-year follow-up of 
patients with early onset AD in paper I.  
When we planned this study, we did expect to find results that indicated a decline in mobility 
with increasing severity of cognitive impairment, based on findings from previous studies and 
clinical experience. However, we anticipated that these differences would be most 
pronounced between the groups of mild and moderate AD. The consistent results of 
differences between the groups of mildest cognitive impairment were therefore more 
surprising to us. Since our longitudinal study is small and the two cross-sectional studies 
make it hard to conclude that we have observed an ongoing decline, it is important to compare 
our results with other studies to see if these strengthen or weaken our findings.  
The findings from cross-sectional studies of walking published in recent years are not 
unambiguous. Differences in walking between healthy elderly and persons with MCI was 
found by Pedersen and colleagues.
235
 Muir et al.
153
 on the other hand did not find any 
differences in gait speed or stride time variability between healthy elderly persons, persons 
with MCI and persons with mild AD; however, they only included persons without a history 
of falls. The participants in the study by Muir et al. may therefore not be representative to the 
general population with MCI and AD, as falls are reported in about 50% of home-dwelling 
elderly with AD.
9
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Longitudinal studies of walking abilities in persons with AD have been published in recent 
years, and the reported findings all indicate a decline in walking performance over time,
236-238
 
which is in line with the results from the longitudinal parts of our study of patients with early 
onset AD (paper I). Two of the papers are from the same small (n = 22 at follow-up) but well-
designed study of home-dwelling patients with AD in Sweden. The results of these two 
studies indicated a deteriorating performance over a two-year period on both clinical gait 
measures
236
 and quantitative gait characteristics.
237
 The third longitudinal study involved a 4-
year follow-up of 686 home-dwelling persons with AD in France, where the authors 
according to the results of the study estimated a yearly decline in walking ability of about 
13%.
238
 The mean age of the participants in Rolland’s study238 was 77.8 years, and older age 
was an important risk factor for a decline of walking performance. In the Swedish study, the 
mean age was 71 years.
236;237
 So, the participants in both these studies were considerably 
older than our participants with early onset AD whose mean age at baseline was 59.7 years. 
Although the changes we observed in our study were of limited importance on an individual 
level, our results still extend the findings from other studies. Our findings indicate that a 
decline in mobility is also present in the youngest patients with AD. Age-related changes and 
comorbidities are likely to be less pronounced in our young persons, and the changes 
observed during the follow-up are therefore likely to be connected to the progress of AD, not 
ageing. We therefore suggest that our longitudinal study in paper I contributes to the view that 
a decline in cognition and mobility are rather parallel processes in patients with an established 
clinical diagnose of AD.  
Relatively few studies have been published on the relation between balance and severity of 
cognitive function, and the most recent studies generally confirm that there are differences in 
balance between healthy elderly and persons with AD,
239;240
 although studies with contrary 
findings have also been published.
241
 The most relevant study that could be compared to our 
study is the one by Suttanon and colleagues.
240
 In their study, balance was treated as a 
multidimensional construct in line with the systems approach in an almost similar manner as 
in our study, and the authors identified differences in all the measured aspects of balance 
between healthy elderly and persons with mild to moderate AD.  
By carrying out a very comprehensive assessment of balance in the continuum of AD, I hoped 
that we could be able to provide new knowledge on which aspects of balance interventions 
should target, and at what stage interventions should be initiated. Since both our study and the 
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study by Suttanon and colleagues
240
 found deficits across all the measured aspects of balance, 
recommendations about interventions targeted towards specific aspects are hard to give. 
However, it is important to note that the last subscale, “Stability in Gait”, had the lowest 
scores (i.e., worst performance) in all of our three groups. The tasks included in this subscale 
are all dynamic, and the tasks challenge biomechanical constraints (e.g. alignment, strength), 
anticipatory and reactive postural responses, sensory information, and also specific cognitive 
demands in the dual task item. So, this subscale may perhaps not represent a subsystem, but 
rather a fusion of the other subsystems. Given the lack of longitudinal studies of balance in 
persons with cognitive impairment and AD, our study has presumably applied the most 
comprehensive assessment of balance in this population, and our findings in papers I and II 
indicate that interventions aimed at maintaining balance and mobility in general should be 
initiated even in the youngest patients and also in patients with MCI.    
Differences in mobility between groups of SCI, MCI and mild AD were also demonstrated for 
spatial navigation in paper III; this is in line with other studies concerning spatial abilities, 
although the outcome measures are not directly comparable. Given that navigational 
impairments are well known in patients with AD, I will dwell a bit more on the results related 
to the MCI group. Despite that we had relatively few patients in the SCI and the MCI group, 
we found that the MCI group spent longer time on all the three components of the Floor Maze 
Test than the SCI group. However, they were more successful than the patients with AD in 
completing the Floor Maze Test without errors. This may reflect how the patients in the MCI 
group cope in real-life with other tasks as well. Given the Winblad criteria
62
 they should have 
no or minimal impairments of complex activities in daily life. However these criteria do not 
address issues like increased effort, modifications of the tasks, time spent doing daily 
activities, or if several attempts are needed. Studies of mobility in elderly without cognitive 
impairments has described increased tiredness or compensation by changes in method, 
frequency, or time used to carry out tasks in the preclinical stages of mobility disability.
242;243
 
Our findings corroborate results from recent studies of worse performance in patients with 
MCI compared to healthy controls and in patients with AD compared to patients with MCI on 
a real-life route learning task.
244
 They also agree with previous study results regarding inferior 
performances on a virtual maze task in patients with MCI compared to healthy controls.
245
 
However, there is still a lack of studies that investigate spatial navigational ability in relation 
to mobility in real-life in the early and intermediate stages of cognitive decline.
246
 The Floor 
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Maze Test is described by the original authors as a test of spatial navigation with real-life 
applicability.
214
 Although this test involves walking, it is still a huge leap to claim real-life 
applicability. In order to be able to identify persons at risk for getting lost, future studies 
should seek to validate the Floor Maze Test, or other simple feasible tests of spatial 
navigation towards real-life navigational measures. Paper III is the most explorative in the 
thesis, both regarding the groups and the outcome we used for assessing spatial navigation 
during walking. The fact that our findings are in line with findings from other studies 
contributes to the trustworthiness of our results; however, this study should primarily be 
considered as hypothesis-generating for future studies. 
Although we found rather large between-group differences of mobility it is important to 
acknowledge the great variability within each group. The variability was most pronounced in 
the groups with most severe cognitive impairments and also worst performances on the 
mobility outcomes. In paper II, the SCI/MCI group had narrow confidence intervals indicative 
of either homogenous performance or ceiling effect on the BESTest (Figure 8). In the two 
other groups, however, the variability within each group was pronounced. In paper III the 
same pattern of variability is observed for performance on the Immediate Maze Time 
component of the Floor Maze Test, as illustrated in Figure 9. So despite the rather large 
differences at the group level, there is considerable variability on the individual level. 
Longitudinal studies would be valuable to determine what characterizes the persons with 
well-preserved mobility despite advanced cognitive impairment, and also those who develop 
mobility impairments early in the course of cognitive decline.  
Longitudinal studies of cognitively healthy elderly people have been published during recent 
years, and the findings from these studies indicate that slow gait precedes and predict 
cognitive decline
247
 and dementia.
248
 The coexistence of slow gait and cognitive complaints in 
persons without impairments of activities of daily living or dementia has even been suggested 
as a “motoric cognitive risk” syndrome.249 In a recent prospective multi-country study, this 
suggested syndrome was a strong and early risk factor for future cognitive decline and 
dementia.
250
 These studies underline our recommendations that interventions aimed to 
maintain mobility may benefit from being initiated as soon as these persons make contact 
with health services.  
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8.2.2 Relationship between mobility and cognitive domains 
In papers II and III we have demonstrated that executive dysfunction was significantly 
associated with mobility (i.e., balance and spatial navigation). This was done in regression 
models that included measures of attention, memory, visuoconstruction, global cognition, and 
demographic factors. The role of executive function for mobility was consistent in our 
analyses, while global cognition as measured by the MMSE did not contribute to the results of 
the regression models in any of the three papers. We were uncertain beforehand if we should 
include the MMSE in the regression models in papers II and III, because we were concerned 
that this global measure would “overshadow” the separate cognitive domains. On the other 
hand, by identifying significant associations between our measures of mobility and executive 
function while controlling for the MMSE, we assume that we have actually strengthened our 
findings. The MMSE is often used to determine severity of cognitive impairment: however, it 
has been criticized for the lack of items related to executive function, and also for being less 
sensitive than other measures in detecting MCI,
251
 which may explain why it did not 
contribute to any of the models in our sample with generally high scores in the MMSE. Our 
findings indicate that the relationship between cognition and mobility applies not only to the 
severity of cognitive function, but also to specific cognitive domain of executive function.  
The relationship between executive function and mobility in terms of gait and balance in 
persons with cognitive impairment and dementia is known from previous
133-135
 and recent 
studies.
232;252;253
 However, I will argue that our studies contribute to an expanded 
understanding of this relationship. In the study by McGough et al.
232
 the association between 
executive function and performance-based measures of mobility (Timed Up and Go and gait 
speed) in sedentary home-dwelling older persons with MCI was established after adjusting for 
age, sex, comorbidity, depressive symptoms, and body mass index. A common shortcoming 
of this and several other studies is that executive function has been the only cognitive domain 
included in the studies. This makes it difficult to evaluate if executive function serves as a 
marker of general cognitive function, or if it is the specific contribution of executive function 
to mobility. By assessing executive function, other cognitive domains, and measures of global 
cognitive function in the same regression analysis, we have made a contribution to strengthen 
the trust of the importance of executive function to mobility. Our study also expands the 
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results from the other studies with the consistent associations between all the aspects of 
balance measured by the BESTest and executive function.  
The rationale for exploring the relationship between the Floor Maze Test, demographic 
factors and cognitive domains was to examine to what degree the independent variables 
explained the performances on the Floor Maze Test, and also to identify which of the 
variables were associated with the Floor Maze Test. This is of course different from the 
rational in paper II, as spatial navigation is a cognitive ability in itself. However, spatial 
navigation is closely linked to real-life mobility, as noted in the special paper concerning 
aging, the central nervous system and mobility that emerged from a workshop hosted at the 
Gerontological Society of America conference in 2012.
254
 Executive function was in our 
study associated with the two components of the Floor Maze Test that involves walking, but 
not with the stationary component Planning Time. This largely corroborates the results from 
the original paper where they performed factor analysis of the neuropsychological test battery, 
and the executive function/attention factor predicted performance on all three Floor Maze 
Test components in adjusted regression models.
214
 The explained variances for the regression 
models are unfortunately not reported in this study.  
In a recent study of route learning performance (i.e., the ability to learn and retrace a route in 
a hospital setting) in groups of normal ageing, MCI and AD, the authors examined how well 
assessments of memory (i.e., word list recall) and executive function (i.e., verbal fluency) 
predicted route learning performance.
244
 Both measures were significantly associated with the 
route learning task, so these findings are in accordance with our results. Similar to our results, 
no demographical factors were significantly associated with route learning performance. 
However, in contrast to our findings, the explained variance of the model in the paper by 
Benke et al.
244
 was as high as 58%. The relationship between the Floor Maze Test and real-
life route learning tests is not established; however, it is still difficult to explain the large 
discrepancy in explained variance between Benke’s and our studies. Benke and collegaues244 
commented that their findings stand in contrast with other studies of route learning, where 
route learning performance was not predicted by neuropsychological measures.
33;198
 The 
literature is thus not consistent regarding the relationship between 
neuropsychological/cognitive test batteries and navigational skills. Our findings contribute to 
the concern that navigational impairments may go undetected, and that efforts should be made 
to address this in diagnostic work.  
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Finally, I would like to once again emphasize that executive function is a complex construct. 
Executive function may be regarded as a separate cognitive domain, but also as executing 
control over the other cognitive domains. Royall
25
 argues that executive function may explain 
some variance in most cognitive measures. The outcomes in our studies are performance-
based outcomes that are characterized by the ability to conduct the tasks according to a set of 
quality-criteria and timed spent conducting these tasks. Given that executive function may be 
characterized as the ability necessary for successful goal-directed behavior,
25
 the relationship 
between executive function and our mobility outcome measures makes sense. It is important 
to keep in mind that real-life mobility is far more demanding than our assessments conducted 
in quiet and undisturbed settings. Clinicians are therefore encouraged to pay attention to 
patients with executive function impairments, as they are likely to have difficulties related to 
mobility in the community.  
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9 Conclusions  
The main aims of this study were to explore how mobility performance differs between 
groups with different levels of cognitive impairment, and to explore the relationship between 
mobility and different domains of cognitive function in home-dwelling and ambulatory 
persons with cognitive impairment and AD.  
We found differences between each of the groups on all aspects of balance (paper II) and also 
on spatial navigation (paper III). In our longitudinal study of early onset AD we also saw a 
small decline in mobility over one year (paper I). Although our findings indicate a decline in 
mobility through the stages from SCI to MCI, mild AD, and moderate AD, these findings 
need to be confirmed in larger longitudinal studies.  
With regard to the second aim, we found consistent associations between executive function 
and all aspects of balance and also between executive function and spatial navigation. For the 
models with the aspects of balance as dependent variables the explained variances were 
generally high, while rather minor explained variances were observed for the models with 
spatial navigation. Future studies are needed to validate the Floor Maze Test against real-life 
navigation.  
9.1 Implications for clinical practice and future 
research 
My main motivation for doing research in the field of dementia and the major idea behind this 
thesis was to provide knowledge that may contribute to helping persons with cognitive 
impairment and dementia to remain independently mobile in the society for as long as 
possible. The findings of this thesis cannot be extended that far, but they suggest directions 
for both research and clinical practice. 
The main reason for exploring mobility across groups of increasing severity of cognitive 
impairment was to try to identify at which stage interventions are needed in order to prevent 
unnecessary decline. Our findings indicate that mobility should be addressed as soon as the 
patients make contact with health services. All participants in our studies were home-dwelling 
and were able to walk without a walking device; still, we observed group-differences of 
impairments in mobility, and also decline over one year in the study of early onset AD. Early 
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intervention, also in the youngest patients, is probably necessary in order to prevent or 
postpone the transition from observed impairments to manifest disability.  
Since we found deficits across all the aspects of balance that we measured, exact 
recommendations about which aspects of balance one should target when planning 
interventions for persons with cognitive impairment and AD are hard to give. The high 
variability in the groups with mild and moderate AD also underlines the need for individual 
assessments. However, the generally low scores on the “Stability in Gait” subscale may 
suggest that it may be beneficial to incorporate tasks that challenge the dynamic balance 
control in during walking. During the last years, intervention studies have combined physical 
exercise and cognitive stimulation specially aimed at executive functions.
241;255
 Although 
these studies have been small and non-randomized, their results are still promising with 
regard to the potential for exploiting the interplay between cognitive and motor function.  
The results from paper III suggest that both persons with MCI and mild AD have difficulties 
with solving spatial navigation tasks. Clinicians should make sure that navigation is properly 
addressed in the clinical interview when patients are attending memory clinics, as the standard 
cognitive test battery does not seem to capture these impairments. The MCI group, and 
perhaps also the mild AD group, may be the ideal target populations for trying modern 
technology such as Global Positioning Systems (GPS) devices, as they are still able to learn 
new technology and also to express their views regarding the integrity of autonomy and 
privacy when considering use of tracking devices. Such GPS equipment may also be useful 
for future studies to measure a person’s out-of-home mobility with far better reliability and 
precision than retrospective interviews.  
Future longitudinal studies with a longer-term follow-up are warranted to confirm the 
impression of progressive decline of mobility from our studies, and also to establish 
predictors for future decline in balance and spatial navigation. Further suggestions also 
involve the use of MRI to compare mobility with location and amount of structural changes in 
the brain. Lastly, we recommend that studies should address the validity of the Floor Maze 
Test as a measure of real-life spatial navigation, and also to provide relevant cut-offs for 
identifying persons at risk for getting lost. 
It is important to remember that all the participants in our studies are home-dwelling and able 
to walk without a walking device. The differences in mobility that we observed are therefore 
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all related to the mild end of a disability spectrum. For most of these persons, physical 
function is therefore not an obstacle for participation in exercise or physical and social 
activities in the community.  
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